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Abstract 
Background: Orphan nuclear receptor estrogen related receptor β (Esrrb or ERRβ) is well known in stem cells and 
early embryonic development. However, little is known about its function in cancer.
Method: We investigated the mRNA profile alterations induced by Esrrb expression and its synthetic ligand DY131 in 
human prostate cancer DU145 cells via RNA-Seq analysis.
Results: We distinguished 67 mRNAs differentially expressed by Esrrb alone. Although DY131 alone did not change 
any gene, treatment of DY131 in the presence of Esrrb altered 1161 mRNAs. These observations indicated Esrrb 
had both ligand-independent and ligand-dependent activity. When Esrrb was expressed, DY131 treatment further 
regulated 15 Esrrb-altered mRNAs. DY131 acted as an antagonist for 11 of 15 mRNAs (wdr52, f13a1, pxdn, spns2, 
loc100506599, tagln, loc441454, tkel1, sema3f, zcwpw2, sdc2) and as an agonist for 4 of the 15 mRNAs (rarres3, oasl, 
padi2, ddx60). Gene ontology analyses showed altered genes are related to transcription and translation regulation, 
cell proliferation and apoptosis regulation, and cellular metabolism.
Conclusion: Our results characterized mRNA profiles in DU145 prostate cancer cells driven by Esrrb expression and 
Esrrb ligand DY131, and provided multiple markers to characterize Esrrb’s function in Esrrb research.
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Background
Esrrb encodes nuclear receptor estrogen related receptor 
β (Esrrb), which belongs to the nuclear receptor family. 
Esrrb acts as a transcription factor by binding to a spe-
cific DNA sequence estrogen related receptor response 
element (ERRE), which is also known as steroid factor 
response element (SFRE), or half site estrogen response 
element [1, 2].
Esrrb, first cloned in 1988, was not intensively studied 
until recent years. Knocking out of Esrrb was embryonic 
lethal due to placental malformation [3]. Though early 
studies showed a very limited range of tissues with posi-
tive Esrrb expression, recent studies reported that short 
form Esrrb alternative splicing isoform had a broad range 
of expression [4]. Esrrb was found to be a core-reprogram-
ming factor to reprogram Pluripotent Stem Cells (iPSCs) 
[3–6]. c-myc and klf4 of the OSKM (oct4, sox2, klf4, c-myc) 
core-reprogramming factors can be replaced by Esrrb [5, 
6]. Esrrb was also recently reported to drive sox2 tran-
scription and induce iPSC in a single cell system [7].
Tumorigenesis and tumor progression are related to 
Esrrb. Esrrb was shown to be down-regulated in prostate 
cancer epithelium compared to normal prostate tissue 
[8–10]. Its re-expression in DU145 and LNCaP cells was 
shown to stimulate tumor suppressor cdkn1a (p21) con-
centration. Also, Esrrb can inhibit Estrogen Receptor tran-
scriptional activity in uterine endometrial cancer cells and 
Nrf2-Keap signaling pathway in breast cancer cells [11, 12].
There are a handful of transcriptome-wide expres-
sion survey data from Esrrb knockdown in both human 
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iPSCs and mouse embryonic stem cells [13–16]. Known 
Esrrb controlled genes include klf4, c-myc, cdkn1a and 
cyp19a1, but Esrrb target genes in cancer cells are still 
not known.
This manuscript focuses on the discovery of Esrrb 
ligand-independent and Esrrb ligand-dependent target 
genes. We performed RNA-Seq analysis to characterize 
Esrrb regulated mRNAs in a prostate cancer cell line and 
we found the treatment of DY131 expanded Esrrb’s tran-
scriptional regulation activity to many more genes.
Results
Establishment of the Esrrb stably transfected DU145 cells
Esrrb expression vector or control pcDNA3.1 (Zeo+) 
vector were transfected into DU145 cells. After 3 weeks 
of Zeocine selection, we characterized the Esrrb status 
by reverse transcriptase (RT)-PCR, qPCR and west-
ern blot analysis (Fig.  1a–c). Our results showed that 
Esrrb was successfully expressed in DU145-Esrrb cells. 
Although RNA-Seq showed that DU145-pc3.1 cells 
had a very small amount of Esrrb expressed (count per 
a
b c
Fig. 1 Characterization of Esrrb-expressing cancer cell line. Esrrb status of two independent replicates of stable transfected control DU145-pc3.1 
and DU145-Esrrb cells are tested by a quantitative PCR b Western blot and c reverse transcriptase PCR. a Relative mRNA concentrations of Esrrb 
were measured by qPCR, Esrrb transcripts concentration were determined by standard curve method and Esrrb concentration were first normal-
ized to the concentration of house keeping gene GAPDH, then normalized to Esrrb/GAPDH ratio of DU145-pc3.1 cells. b Total protein was extracted 
form HEK293, DU145-Esrrb and control DU145-pc3.1 cells. Protein concentration of Esrrb was determined by western blot using GAPDH as internal 
control. c RT-PCR was performed on total RNA extracted from HEK293, DU145-esrrb and control DU145-pc3.1 cells. Esrrb was expressed in DU145-
Esrrb cells, while Esrrg is not expressed in either DU145-pc3.1 and DU145-Esrrb cells
Page 3 of 23Lu et al. BMC Molecular Biol  (2015) 16:21 
million read <1), the Esrrb concentration is below the 
detection limit of RT-PCR and western blot. Compared 
to HEK293 cells, which expressed endogenous Esrrb, 
overexpression of Esrrb in DU145 cells raised the Esrrb 
protein concentration to a comparable physiological 
concentration (Fig. 1b). In addition, our RT-PCR results 
and RNA-seq results confirmed the estrogen related 
receptor gamma (Esrrg) was not expressed in DU145 
cells. The absence of Esrrg eliminated any possible 
functional contamination by Esrrg in our Esrrb studies 
(Fig. 1c).
Esrrb expression alters mRNA profile
To distinguish genes regulated by Esrrb, we performed 
RNA-Seq analysis on cDNA libraries constructed from 
two biological replicates of both DU145-pc3.1 and 
DU145-Esrrb cells. Spearman ranking correlation analy-
sis showed that the expression of Esrrb in DU145 created 
a distinct transcriptome compared to control DU145-
pc3.1 cells (Fig.  2a). We found 67 genes (21 genes up-
regulated, 46 genes down-regulated) altered due to Esrrb 
expression (Fig. 2b; Table 1). Seven genes that are among 
the most changed genes (zcwpw2, hoxb8, tagln, f13a1, 
pxdn, aox1, and bmp4, as well as tgfβ as a negative con-
trol) were confirmed by qPCR (Fig.  3). Gene ontology 
(GO) analysis shows that the products of Esrrb driven 
differentially expressed genes fell into functional catego-
ries of regulation of cell development as well as immune 
responses (Table 2).
DY131 requires Esrrb to affect gene expression
To get a more comprehensive understanding of Esrrb-
regulated genes and characterize Esrrb’s potential ligand 
dependent activity, control DU145-pc3.1 and DU145-
Esrrb cells were treated with Esrrb/Esrrg synthetic ligand 
DY131. Since both qPCR and RNA-seq show Esrrb tran-
script concentration is extremely low in DU145 cells 
and Esrrg is absent, and Esrrb protein concentration is 
also below the detection limit of western-blot analysis, it 
was not surprising to observe DY131 treatment without 
Esrrb expressed did not result in any gene differentially 
expressed (Fig.  4a). After we applied DY131 to DU145-
Esrrb cells, we found DY131 treatment most significantly 
modified the transcriptome (Figs.  2a, 4b). Further com-
parison of DU145-Esrrb cells alone to DY131-treated 
DU145-Esrrb cells detected 1161 altered mRNAs (861 
down-regulated, 300 up-regulated). 15 of them over-
lapped with Esrrb-induced mRNA alterations (Fig.  4c, 
d; Table 3). We defined an Esrrb agonist as a ligand that 
moves the mRNA concentration in the direction as Esrrb 
does; and an antagonist moves the concentration in the 
opposite direction as Esrrb does. By comparing the trend 
of the altered genes induced by Esrrb expression and 
DY131 treatment, DY131 acts as an agonist for 4 of the 15 
genes, and an antagonist for 11 of the 15 genes (Fig. 4d). 
There are another 1146 mRNAs changed with both Esrrb 
and DY131 treatment compared to Esrrb alone, indicat-
ing their responses is ligand-dependent (Table 3).
GO analysis showed Esrrb-dependent DY131 up-reg-
ulated genes were important for regulation of transcrip-
tion, regulation of apoptosis and proliferation, and a 
Fig. 2 Transcriptome correlation and Esrrb altered mRNAs. a 
Transcriptome correlation analysis was performed using Spearman 
Ranking Correlation. Color represents the correlation coefficient. 
DY131 treatment to DU145-Esrrb cells results in the lowest correlation 
coefficient with DU145-pc3.1 cells. b Dot plot of Esrrb-induced gene 
expression alteration. Genes expressed at adequate level are tested 
for differential gene expression test. The plot was made by plotting 
the Log2FC (fold change) against the Log2 cpm (count-per-million) 
difference. Red color marks the genes that are significant differentially 
expressed (FDR < 0.05), and the blue lines marked the Log2FC cutoff 
value (Log2FC > 1 or Log2FC < −1). 67 genes passed both thresholds
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majority of down-regulated genes are related to oxidation 
and reduction, metabolism and translation elongation 
(Table 4; Additional file 1: Table S1).
Discussion
Esrrb has gained lots of attention in recent years because 
of its biological function in stem cells and its ability to 
reprogram somatic cells to iPSC with oct4 and sox2 [6, 13, 
17–21]. Several other functions of Esrrb have also been 
discovered including alteration of energy balance, estro-
gen receptor and glucocorticoid receptor transcription 
function modulation, Keap1-Nrf2 signaling inhibition, 
and tumorigenesis in prostate cancer and endometrial 
adenocarcinoma [9–12, 22–25]. But transcriptome-wide 
Esrrb function and Esrrb-regulated genes in cancer cells 
are not well studied.
Esrrb was reported by Chan et al. as a tumor suppres-
sor in DU145 and LNCaP prostate cancer cells using 
both in vitro and in vivo models [9]. Expression of Esrrb 
induced p21/cdkn1a by directly binding to an ERRE in 
p21/cdkn1a’s promoter, arrested cell cycle at S-phase, 
and significantly inhibited cell growth [9, 26]. Interest-
ingly, we did not find p21/cdkn1a up-regulation after 
Esrrb expression alone, but after we treated DU145 cells 
with 3  μM DY131, we observed a significant increase 
of p21/cdkn1a mRNA (Table 3; Additional file 2: Figure 
S1). Scrutinizing the data revealed that Chan’s lab cul-
tured their cells with full serum, while we used charcoal-
stripped serum for cell culture and DY131 treatment [9]. 
Table 1 Esrrb altered mRNAs
Gene symbol logFC P value FDR
AOX1 −3.49 4.89E−184 3.19E−180
PXDN −2.79 4.45E−87 1.16E−83
F13A1 −2.68 9.28E−114 4.04E−110
BMP4 −2.59 1.69E−29 1.16E−26
NPTX1 −2.11 1.06E−46 1.73E−43
SPNS2 −1.70 8.70E−31 7.09E−28
DDX60 −1.61 2.43E−15 4.46E−13
NEFL −1.61 1.84E−13 2.85E−11
OASL −1.60 1.30E−25 7.07E−23
IFIT3 −1.60 4.29E−42 5.09E−39
WDR52 −1.50 1.85E−06 7.40E−05
C3 −1.43 7.81E−09 5.73E−07
LOC344887 −1.41 5.01E−20 1.49E−17
PCDHB15 −1.41 6.25E−06 0.00020978
CXorf57 −1.41 1.78E−10 1.92E−08
IFI6 −1.38 1.09E−19 2.91E−17
CXCR4 −1.32 3.23E−06 0.00011537
GBP1 −1.31 1.43E−07 7.57E−06
IGFBP3 −1.31 3.19E−89 1.04E−85
ZSCAN12P1 −1.30 0.00015585 0.00302695
RNF128 −1.29 1.58E−10 1.73E−08
SAMD9 −1.29 2.69E−22 1.13E−19
UNC5A −1.28 8.28E−07 3.62E−05
MX2 −1.27 1.68E−06 6.86E−05
SSBP2 −1.26 5.96E−05 0.00141054
MX1 −1.25 5.99E−22 2.37E−19
SULT4A1 −1.20 4.94E−05 0.00120711
DPYD −1.19 1.35E−05 0.00040257
NEBL −1.18 1.16E−12 1.62E−10
TAGLN −1.18 5.48E−30 3.97E−27
INA −1.17 2.47E−05 0.0006739
BMF −1.16 3.32E−05 0.00085559
ESRP1 −1.13 0.00014206 0.00283503
GJA3 −1.12 1.38E−05 0.00040614
IFIT2 −1.11 1.02E−19 2.76E−17
LOC1005065 −1.10 8.53E−05 0.0018618
RARRES3 −1.07 1.84E−07 9.68E−06
TMEM45A −1.06 4.69E−06 0.00016245
LGALS3BP −1.05 4.57E−17 9.63E−15
ERAP2 −1.05 1.83E−50 3.41E−47
WNT10A −1.05 0.00024417 0.00440189
PADI2 −1.04 1.13E−17 2.55E−15
REEP1 −1.01 0.00024704 0.0044413
AMIGO2 −1.01 8.26E−45 1.08E−41
HES1 −0.98 1.30E−07 7.01E−06
FRMD4B −0.98 0.00014442 0.00284746
NRIP3 0.97 4.28E−14 6.90E−12
HOXB8 0.98 3.60E−11 4.33E−09
KCNQ5 0.98 5.87E−08 3.55E−06
Table 1 continued
Gene symbol logFC P value FDR
COX6B2 0.99 1.24E−07 6.77E−06
PPFIBP2 1.04 6.38E−07 2.92E−05
KIAA1199 1.06 1.21E−25 6.89E−23
BST1 1.08 4.97E−13 7.30E−11
LOC1001336 1.13 0.00019921 0.00370382
SMOC1 1.15 1.52E−06 6.32E−05
LOC441454 1.15 9.40E−06 0.00029713
DDIT4L 1.18 2.28E−10 2.39E−08
SEMA3F 1.27 2.08E−20 6.96E−18
DUOX1 1.35 5.37E−09 4.25E−07
ARHGAP24 1.39 6.40E−10 6.01E−08
CDHR1 1.44 2.04E−06 7.93E−05
SDC2 1.44 1.49E−08 1.04E−06
SH3RF3 1.44 1.32E−05 0.00039562
PRSS8 1.45 6.96E−06 0.00022989
TKTL1 1.90 3.68E−21 1.33E−18
FGB 1.96 5.57E−22 2.27E−19
ZCWPW2 5.22 3.47E−215 4.53E−211
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This implies that there is a compound or factor that can 
be removed by charcoal treatment modulated Esrrb’s 
activity [27, 28].
From the Esrrb-regulated gene list, we found a few tar-
get genes that are related to the known function of Esrrb. 
Kiaa1199 encoded gene product has been shown to asso-
ciate with cellular mortality. A kiaa1199 mutation was 
reported to relate to nonsyndromic hearing loss. Consid-
ering the significant effect of Esrrb mutations on human 
hearing loss, kiaa1199 could be a mediator of Esrrb 
mutant related hearing loss [29–32] [33–36]. Another 
interesting Esrrb responsive gene is tagln (Transgelin). It 
was inhibited by Esrrb while DY131 treatment relieved 
the inhibition. Tagln was reported to promote DU145 cell 
migration and invasion, indicating Esrrb can also affect 
DU145 cell behavior by affecting tagln [37].
Judging by the numbers of altered genes induced by 
Esrrb with or without DY131, and the result that DY131 
did not alter any mRNA in the absence of Esrrb, we con-
clude that DY131 activity is Esrrb-dependent.
Fig. 3 Esrrb-regulated mRNA validation. Left panel qPCR validation of Esrrb-regulated mRNAs. Expression values were firstly normalized to Gapdh 
and normalized ratios are further normalized to that of DU145-pc3.1. Error bars represent standard deviation. Student t test was performed for 
statistical analysis (*p < 0.05). Seven genes were differentially expressed in both RNA-seq and qPCR, 1 gene, TGFbeta, is not differentially expressed 
in either assay and serves as a negative control. Right panel RNA-Seq analysis result, fold change (FC) indicates the ratio of normalized read counts in 
DU145-Esrrb to that of DU145-pc3.1
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Conclusions
In conclusion, we characterized the transcriptome altera-
tion induced by Esrrb expression as well as Esrrb with 
its ligand DY131 in prostate cancer cells. We conclude 
Esrrb-target synthetic ligand requires Esrrb to generate 
its gene expression modulation effect. Finally, analysis of 
Esrrb target genes indicates Esrrb may be an important 
factor in regulating cell proliferation.
Methods
Cell culture and reagents
DU145 (ATCC Number: HTB-81) and HEK293 (ATCC 
number: CRL-1571) cells were obtained from the Ameri-
can Type Culture Collection (ATCC). DU145 cells were 
cultured in RPMI1640 media (Invitrogen, Grand Island, 
NY, USA) with 10  % Fetal Bovine Serum (FBS) (GE 
Healthcare Life Sciences, Logan, UT, USA). HEK293 
cells were cultured in Eagle’s Minimal Essential Medium 
(DMEM) (Invitrogen, Grand Island, NY, USA) with 10 % 
FBS. 70  % confluent DU145 cells were transfected with 
either pcDNA3.1-zeo (+)-Esrrb expression vector [4], or 
control empty vector pcDNA3.1-zeo (+) (Promega, Mad-
ison, WI, USA). Empty vector or Esrrb expression vec-
tor transfected DU145 cells were maintained in medium 
containing 150 μg/ml Zeocine (Invitrogen, Grand Island, 
NY, USA) for 3 weeks for selection. Two biological repli-
cates of DU145 cells transfected with Esrrb were pooled 
together respectively and were named DU145-Esrrb. Two 
biological replicates of DU145 cells transfected with con-
trol vector were pooled together respectively and were 
named DU145-pc3.1. Total RNA and protein were col-
lected from cells after they are confluent in 60 mm petri 
dishes, cultured with phenol-red free RPMI1640 with 
10 % Charcoal-stripped FBS [38]. For DY131 (Tocris Bio-
science, Bristol, UK) treatment, cells are plated in 60 mm 
petri dishes until confluent; DU145-pc3.1 and DU145-
Esrrb are incubated with 3 μM DY131 diluted in medium 
with charcoal-stripped FBS for indicated length of time.
Western‑blot
Total protein was isolated from DU145-pc3.1, and 
DU145-Esrrb cells. 20  μg protein was loaded on 9  % 
SDS gels. After the proteins were transferred to nitrocel-
lulose membrane, the membrane was blocked and then 
incubated with 1:2000 diluted monoclonal anti-Esrrb 
mouse IgG (R&D system, Cat. no: PP-H6705-00) and 
1:2000 diluted polyclonal anti-GPADH rabbit IgG (Santa 
Cruz, Dallas, TX, USA, Cat. no: sc-25777) at 4 degrees 
overnight. The membrane was then washed and incu-
bated with anti-mouse or anti-rabbit secondary antibody. 
Chemoluminescence (Promega, Madison, WI, USA) sig-
nals were collected using x-ray films (Fisher Scientific, 
Pittsburg, PA, USA).
Reverse transcriptase PCR and quantitative PCR
Total RNA was isolated and purified from DU145-pc3.1 
and DU145-Esrrb using RNeasy kit (Qiagen, Venlo, Neth-
erlands). 1000 ng of total RNA was used to create cDNA 
libraries using Superscript III Reverse Transciptase with 
random primers and oligodT (Invitrogen, Grand Island, 
NY, USA). Esrrb mRNA concentration was determined 
using quantitative PCR (qPCR) (iQ SYBR, BioRad, Her-
cules, CA, USA) on ABI7500 system (Applied Biosys-
tems, Foster City, CA, USA). PCR condition: 95°, 30  s; 
60°, 40 s; 72°, 40 s. Each qPCR test was performed three 
times on each of the two biological replicates. Primer 
sequences: zcwpw2 (Genbank: NM_001040432): for-
ward primer: AACAGGGTTGTCTGTGAGACGGA; 
reverse primer: TGCAGGAGCTTCTGGGCTGC. hoxb8 
(Genbank: NM_024016): forward primer: GATGCGCC 
CGCAAGCAGC; reverse primer: CCCAGGGCGT 
GCGATACCTC. tagln (Genbank: NM_001001522): for-
ward primer: ATGCCCCGGATGACTTGGCT; reverse 
primer: GCCATGTCTGGGGAAAGCTCCT. f13a1 
(Genbank: NM_000129): forward primer: TGTTCCGT 
GAAATCCGGCCC; reverse primer: TGCACGTCC 
AG CTCGCCATA. pxdn (Genbank: NM_012293): for-
ward primer: GCAAGCATTTAA GGGACTTGCCT 
CT; reverse primer: GCAAAAATAGCCTCTCGAGCTT 
CGG. aox1 (Genbank: NM_001159): forward primer: 
TACGTGAACGGCCGCAAGGT; reverse primer: 
TGGCTGGGTGATGCCTTATCCT. bmp4 (Genbank: 
NM_001202): forward primer: CCACCACGAAGAA 
CA TCTGGAG; reverse primer: GCCCCTTTCCCAAT 
CAGGGC. tgfβ: (Genbank: NM_000660) forward 
Table 2 Gene ontology analysis of Esrrb altered mRNAs
Term Count P value
GO:0060284 ~ regulation of cell development 5 0.006
GO:0006955 ~ immune response 8 0.012
GO:0009611 ~ response to wounding 7 0.012
GO:0042542 ~ response to hydrogen peroxide 3 0.017
GO:0050767 ~ regulation of neurogenesis 4 0.022
GO:0006800 ~ oxygen and reactive oxygen species 
metabolic process
3 0.024
GO:0060052 ~ neurofilament cytoskeleton organiza-
tion
2 0.029
GO:0000302 ~ response to reactive oxygen species 3 0.03
GO:0051960 ~ regulation of nervous system develop-
ment
4 0.032
GO:0031960 ~ response to corticosteroid stimulus 3 0.038
GO:0010035 ~ response to inorganic substance 4 0.038
GO:0045661 ~ regulation of myoblast differentiation 2 0.039
GO:0048667 ~ cell morphogenesis involved in neuron 
differentiation
4 0.04
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primer:  AGTGGACATC AACGGGTTCAC; reverse 
primer: CGCACGCAGCAGTTCTTCTC. gapdh: (Gen-
bank: NM_001256799); forward primer:  ACCCACT 
CCTCCACCTTTG; reverse primer: CTCTTGTGCT 
CTTGCTGGG. Esrrb: (Genbank: NM_004452) forward 
primer: CAAGAAGCTCAAGGTGGAGAAGGAGGAG; 
reverse primer: CGGTCTGTCC GTTTGTCTGTCTGTA 
GGT. Esrrg: (Genbank: NM_001134285) forward primer: 
ACCATGAATGGCCATCAGA A; reverse primer: ACC 
AGCTGAGGGTTCAGGTAT.
Deep sequencing and differentially expressed genes
2500  ng total RNA from two biological replicates was 
used to generate cDNA libraries using TruSeq Stranded 
mRNA Sample Preparation kits (Illumina, San Diego, 
CA, USA). RNA quality and fragment sizing of cDNA 
a b
c d
Fig. 4 mRNA alteration by DY131 requires Esrrb expression. a DY131 treatment alone did not alter the expression of any gene. In contrast, when 
Esrrb was expressed, b DY131 altered 1161 mRNAs. c Venn Diagram of pairwise comparisons of altered mRNAs showed 15 (p = 0.0014) Esrrb altered 
mRNAs can be further regulated by DY131 treatment (overlap between Esrrb vs. control and Esrrb + DY131 vs. Esrrb). d Heat map of mRNA con-
centration of the 15 genes that response to both Esrrb expression as well as DY131 treatment. Log2-transformed normalized read counts of these 
15 genes were color coded. DY131 is an agonist for 4 mRNAs that are responsive to Esrrb, while it is an antagonist of Esrrb in regulating the other 11 
mRNAs
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Table 3 DY131 altered mRNAs when Esrrb is expressed
Gene symbol logFC P value FDR
MTRNR2L8 −6.83 0 0
MTRNR2L10 −5.31 9.85E−242 4.62E−239
SNHG5 −5.11 1.21E−277 6.66E−275
RPS29 −4.91 0 0
SEC61G −4.48 2.94E−165 7.90E−163
RPL36A −4.35 2.3501596881585 0.00E+00
RPL12 −3.62 0 0
TMEM212 −3.60 1.12E−56 4.20E−55
ESRG −3.58 6.76E−114 9.61E−112
NEDD8-MDP1 −3.47 7.24E−102 7.97E−100
FOS −3.34 2.98E−53 9.94E−52
SLIRP −3.28 1.01E−127 1.85E−125
MTRNR2L1 −3.12 0 0
LGALS3 −2.94 3.19E−115 4.69E−113
SYTL1 −2.93 9.57E−29 1.23E−27
CLIC3 −2.80 7.42E−29 9.60E−28
WISP2 −2.80 7.36E−56 2.71E−54
ABCD3 −2.74 5.71E−21 4.79E−20
TNNT1 −2.69 4.26E−53 1.42E−51
RPL31 −2.68 0 0
ASS1 −2.66 2.78E−30 3.82E−29
EGR1 −2.63 0 0
PSMA1 −2.57 3.99E−89 3.55E−87
MRPL4 −2.56 5.21E−98 5.36E−96
ACPI −2.55 8.68E−27 1.02E−25
USMG5 −2.54 4.08E−124 6.97E−122
CRIP1 −2.52 7.63E−155 1.76E−152
STAT4 −2.46 5.11E−22 4.64E−21
NDUFA11 −2.45 2.16E−93 2.05E−91
SCFD1 −2.44 6.21E−304 4.14E−301
CYBA −2.44 5.78E−17 3.76E−16
NAPSA −2.43 2.66E−17 1.77E−16
RPL13AP5 −2.43 0 0
RPL9 −2.42 0 0
TCTEX1D2 −2.41 6.26E−19 4.62E−18
MKNK2 −2.35 4.60E−83 3.57E−81
RPL18 −2.35 0 0
MUC1 −2.33 2.97E−73 1.75E−71
SEPP1 −2.33 4.57E−14 2.42E−13
PDE9A −2.32 1.44E−65 7.05E−64
SEMA6B −2.32 1.67E−53 5.59E−52
RPS15A −2.30 0 0
CNTN1 −2.29 3.68E−18 2.58E−17
CA11 −2.28 8.82E−26 9.90E−25
TXN −2.27 0 0
LOC728730 −2.26 4.28E−15 2.45E−14
GSTM1 −2.26 3.08E−39 6.17E−38
MACROD1 −2.26 5.25E−17 3.42E−16
CBLC −2.25 5.56E−23 5.30E−22
SUCLG2 −2.24 7.28E−112 9.70E−110
PDCD4 −2.21 4.54E−103 5.13E−101
NDUFB2 −2.16 8.58E−73 4.91E−71
C4orf48 −2.16 1.10E−16 7.00E−16
Table 3 continued
Gene symbol logFC P value FDR
PIR-FIGF −2.15 1.69E−35 2.92E−34
DHRS3 −2.13 4.91E−20 3.92E−19
RPL38 −2.12 4.53E−247 2.20E−244
COX17 −2.11 5.14E−26 5.86E−25
NFE2 −2.10 7.00E−10 2.63E−09
RAB26 −2.09 1.66E−09 6.04E−09
NAPRT1 −2.09 1.48E−116 2.20E−114
CDK5 −2.08 1.31E−28 1.67E−27
NUCB2 −2.08 2.91E−88 2.49E−86
CEBPD −2.07 5.29E−83 4.08E−81
DYNC2LI1 −2.07 5.50E−21 4.63E−20
RPL34 −2.06 6.26E−174 1.88E−171
SNRPF −2.06 3.85E−103 4.39E−101
BCKDHB −2.05 9.69E−26 1.09E−24
ANXA1 −2.04 0 0
RARS2 −2.04 4.40E−37 8.15E−36
CYP4F11 −2.04 1.11E−18 8.08E−18
SPC24 −2.03 1.42E−17 9.58E−17
PTP4A3 −2.02 4.47E−19 3.34E−18
LOC728190 −2.02 1.35E−12 6.39E−12
PSME1 −2.01 1.62E−81 1.20E−79
POLE2 −2.00 3.59E−57 1.37E−55
NSMCE4A −2.00 1.78E−61 7.54E−60
FRA10AC1 −2.00 6.45E−43 1.50E−41
RPS12 −2.00 2.44E−295 1.47E−292
MTRNR2L2 −2.00 4.85E−167 1.33E−164
TYMP −2.00 1.58E−35 2.74E−34
RPL11 −2.00 0 0
CCDC152 −1.99 6.61E−10 2.49E−09
MXD3 −1.96 3.65E−27 4.38E−26
IL17RC −1.95 3.51E−23 3.39E−22
GRB7 −1.95 1.64E−32 2.49E−31
LOC441454 −1.94 8.75E−10 3.24E−09
PCCA −1.94 1.00E−21 8.91E−21
ACBD4 −1.94 2.15E−40 4.51E−39
APLP1 −1.93 7.74E−24 7.77E−23
QARS −1.93 2.90E−156 6.93E−154
STX8 −1.93 7.69E−26 8.67E−25
TM2D1 −1.92 8.60E−25 9.14E−24
C17orf61 −1.92 1.03E−53 3.49E−52
LOC100507156 −1.91 2.19E−24 2.27E−23
KCNAB2 −1.89 1.65E−43 3.93E−42
CERS4 −1.88 1.66E−27 2.01E−26
C18orf8 −1.86 1.06E−73 6.36E−72
NOTCH3 −1.86 1.46E−16 9.26E−16
LHPP −1.86 1.93E−12 9.03E−12
GNG7 −1.85 2.37E−13 1.19E−12
RTN2 −1.85 2.10E−09 7.55E−09
SEMA3B −1.84 2.45E−16 1.52E−15
IL6 −1.84 5.35E−17 3.49E−16
LOC644961 −1.84 1.43E−11 6.24E−11
JPX −1.83 7.74E−11 3.17E−10
CHCHD6 −1.83 7.00E−19 5.14E−18
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Gene symbol logFC P value FDR
PNPLA6 −1.83 3.33E−86 2.77E−84
FBLN1 −1.82 5.31E−33 8.33E−32
SIDT2 −1.81 5.19E−40 1.07E−38
DEPTOR −1.81 1.85E−10 7.26E−10
ZNF826P −1.81 1.25E−08 4.21E−08
TTC39A −1.81 4.87E−17 3.18E−16
TM7SF2 −1.81 1.91E−67 9.80E−66
ELMO3 −1.81 2.54E−22 2.33E−21
OOEP −1.81 8.06E−10 3.00E−09
DNAJC17 −1.81 1.40E−14 7.72E−14
TCEA2 −1.80 1.83E−36 3.29E−35
SLC22A18 −1.80 1.89E−19 1.45E−18
ALDH3B1 −1.80 3.28E−68 1.70E−66
LOC100130872 −1.80 6.08E−10 2.30E−09
ETFA −1.79 1.34E−136 2.74E−134
THYN1 −1.79 9.07E−41 1.92E−39
AKR1C3 −1.78 1.37E−10 5.47E−10
MT1F −1.78 1.45E−08 4.86E−08
PIP5KL1 −1.78 2.53E−10 9.85E−10
ATP5D −1.78 1.68E−44 4.13E−43
TMEM120A −1.77 1.49E−25 1.64E−24
OSBPL5 −1.77 3.00E−09 1.06E−08
TENC1 −1.77 2.65E−18 1.89E−17
EPHX2 −1.76 3.95E−14 2.10E−13
WDR83 −1.76 4.37E−26 4.99E−25
RUVBL2 −1.75 8.63E−147 1.95E−144
KAZALD1 −1.75 6.39E−22 5.77E−21
RPA3 −1.74 6.68E−41 1.42E−39
NOXA1 −1.74 1.23E−09 4.49E−09
TMEM110-MUSTN1 −1.74 5.21E−08 1.65E−07
CACNA2D2 −1.74 8.47E−10 3.14E−09
DICER1-AS1 −1.73 5.04E−10 1.91E−09
ABHD14A-ACY1 −1.73 1.20E−36 2.19E−35
GRAMD2 −1.73 5.14E−08 1.63E−07
PPIH −1.73 2.97E−19 2.25E−18
STXBP2 −1.73 2.73E−72 1.55E−70
C10orf10 −1.73 3.54E−21 3.02E−20
PLA2G6 −1.73 5.59E−14 2.93E−13
CHEK2 −1.72 1.79E−46 4.82E−45
SPAG4 −1.72 2.30E−15 1.34E−14
COG6 −1.71 9.36E−37 1.71E−35
TBC1D17 −1.71 7.78E−24 7.79E−23
IFT52 −1.71 6.78E−38 1.30E−36
GARNL3 −1.71 7.22E−11 2.96E−10
DLST −1.70 2.44E−25 2.67E−24
ACSF2 −1.69 3.58E−13 1.77E−12
RYR1 −1.69 4.48E−09 1.57E−08
LOC100134713 −1.68 3.06E−12 1.41E−11
P2RY6 −1.68 7.55E−21 6.27E−20
RARRES3 −1.68 3.75E−07 1.09E−06
C11orf80 −1.67 5.34E−14 2.81E−13
ELF3 −1.67 2.30E−48 6.58E−47
ADCK4 −1.67 2.68E−40 5.60E−39
Table 3 continued
Gene symbol logFC P value FDR
GLB1L −1.67 5.33E−14 2.80E−13
LPPR3 −1.67 1.58E−24 1.66E−23
CDK7 −1.67 1.76E−36 3.16E−35
SLC6A3 −1.66 8.34E−08 2.58E−07
ADAM22 −1.66 2.07E−12 9.64E−12
EIF3K −1.66 1.65E−98 1.73E−96
S100A4 −1.65 7.75E−10 2.89E−09
ANXA6 −1.65 2.84E−85 2.35E−83
IFT140 −1.65 1.33E−25 1.48E−24
PDIA5 −1.65 1.47E−23 1.44E−22
FADS3 −1.65 2.21E−48 6.32E−47
KCNK15 −1.64 4.58E−21 3.89E−20
FKBP10 −1.64 8.94E−41 1.89E−39
ACSS2 −1.64 1.07E−94 1.06E−92
GSTA4 −1.64 2.80E−31 4.04E−30
KCNMB4 −1.64 8.53E−07 2.38E−06
RPLP2 −1.63 3.48E−220 1.52E−217
UROS −1.63 2.54E−42 5.73E−41
IFT27 −1.63 4.67E−19 3.49E−18
TRAPPC9 −1.63 6.82E−28 8.44E−27
ADAMTSL4 −1.62 5.48E−43 1.28E−41
EIF3E −1.62 3.34E−248 1.69E−245
ACY1 −1.62 2.83E−30 3.87E−29
MT1X −1.62 4.27E−24 4.36E−23
LOC643406 −1.61 4.55E−16 2.79E−15
FBXO36 −1.61 1.48E−14 8.12E−14
PACSIN1 −1.61 5.93E−08 1.87E−07
NIT2 −1.61 4.39E−45 1.10E−43
FUZ −1.60 3.08E−12 1.42E−11
RPL37 −1.60 2.00E−301 1.27E−298
ALDH4A1 −1.60 2.17E−17 1.45E−16
PDCD5 −1.60 6.19E−65 2.92E−63
MFSD3 −1.60 3.51E−31 5.00E−30
EML3 −1.60 1.27E−64 5.92E−63
PSMA3 −1.60 1.93E−96 1.96E−94
TRPT1 −1.59 2.64E−23 2.56E−22
ALDH6A1 −1.59 9.68E−21 8.00E−20
LOC283038 −1.59 3.12E−11 1.32E−10
BDH2 −1.59 1.27E−17 8.59E−17
SDHB −1.59 1.43E−70 7.78E−69
ARHGEF25 −1.59 1.35E−29 1.79E−28
CYS1 −1.58 4.38E−08 1.40E−07
C8orf45 −1.58 4.42E−08 1.41E−07
GLTSCR2 −1.57 4.94E−46 1.30E−44
JMJD8 −1.57 3.93E−28 4.90E−27
ANKRD24 −1.57 1.17E−07 3.56E−07
SNURF −1.57 6.25E−68 3.23E−66
SNRPN −1.57 6.43E−68 3.31E−66
RCN3 −1.57 1.28E−15 7.56E−15
LACTB2 −1.57 2.50E−78 1.75E−76
HSF4 −1.56 1.23E−13 6.27E−13
ENDOV −1.56 4.24E−09 1.48E−08
CPT1C −1.55 4.07E−07 1.17E−06
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Gene symbol logFC P value FDR
ITFG1 −1.55 1.10E−88 9.66E−87
IL11RA −1.55 2.61E−11 1.12E−10
FRG1 −1.55 2.08E−08 6.87E−08
CCDC104 −1.54 8.93E−31 1.25E−29
CERS1 −1.54 4.07E−08 1.30E−07
GDF1 −1.54 4.07E−08 1.30E−07
USP4 −1.54 4.05E−13 2.00E−12
PLCD1 −1.54 6.66E−14 3.47E−13
PBXIP1 −1.54 5.25E−37 9.70E−36
NDUFC1 −1.54 1.61E−42 3.66E−41
CEP70 −1.54 5.71E−59 2.29E−57
MFSD4 −1.54 2.40E−07 7.10E−07
ARPC4-TTLL3 −1.53 3.34E−25 3.64E−24
XRCC1 −1.53 7.89E−35 1.33E−33
CLDN4 −1.52 2.47E−20 2.00E−19
VWA5A −1.52 7.77E−10 2.90E−09
PC −1.52 1.73E−20 1.41E−19
MMP11 −1.52 1.58E−09 5.74E−09
C9orf84 −1.52 1.04E−28 1.33E−27
SLC37A2 −1.52 1.08E−06 2.99E−06
SUPT3H −1.52 5.13E−12 2.33E−11
SLC44A3 −1.52 1.17E−11 5.15E−11
UNC93B1 −1.52 6.48E−37 1.19E−35
SLC38A6 −1.52 1.32E−13 6.69E−13
NDUFA1 −1.51 4.88E−40 1.01E−38
TMEM205 −1.51 4.08E−37 7.58E−36
ZCRB1 −1.51 2.46E−88 2.13E−86
BRSK1 −1.50 7.65E−10 2.86E−09
HDAC5 −1.50 3.47E−33 5.53E−32
RNASEH2B −1.50 1.90E−22 1.76E−21
CLASRP −1.50 4.14E−23 3.98E−22
CAMK1 −1.50 1.12E−21 1.00E−20
C11orf10 −1.49 1.26E−42 2.91E−41
PRKCSH −1.49 5.06E−129 9.41E−127
PMF1-BGLAP −1.49 3.71E−34 6.12E−33
NFASC −1.49 1.16E−05 2.86E−05
LTBP4 −1.49 2.21E−61 9.29E−60
LAMA5 −1.49 2.31E−160 6.08E−158
LRSAM1 −1.49 5.65E−26 6.42E−25
CTSH −1.48 6.14E−31 8.67E−30
HEXB −1.48 7.22E−108 8.96E−106
MGST2 −1.48 1.97E−09 7.13E−09
FAH −1.48 8.07E−22 7.23E−21
PEX7 −1.48 2.91E−14 1.56E−13
C5 −1.48 1.05E−11 4.64E−11
ACADS −1.48 2.02E−21 1.76E−20
IFT43 −1.47 9.38E−15 5.24E−14
JAK3 −1.47 6.46E−12 2.90E−11
MRPL39 −1.47 1.89E−45 4.88E−44
SLC43A1 −1.47 3.84E−08 1.23E−07
EFEMP2 −1.47 9.20E−07 2.56E−06
SSBP4 −1.47 1.48E−14 8.14E−14
IMMP1L −1.47 1.82E−07 5.46E−07
Table 3 continued
Gene symbol logFC P value FDR
GPR108 −1.47 1.33E−60 5.50E−59
WDR54 −1.46 4.01E−38 7.75E−37
ARHGAP8 −1.46 4.37E−14 2.32E−13
RPL35A −1.46 8.72E−183 2.76E−180
GBP2 −1.46 7.43E−12 3.31E−11
TECR −1.46 1.15E−73 6.86E−72
AUH −1.46 1.97E−08 6.54E−08
PRR5-ARHGAP8 −1.46 1.99E−14 1.08E−13
LINC00263 −1.45 7.89E−17 5.07E−16
PDLIM2 −1.45 2.48E−44 6.06E−43
RASA2 −1.45 1.41E−19 1.09E−18
PTPN6 −1.45 1.25E−36 2.27E−35
PARL −1.45 2.07E−65 1.00E−63
CERCAM −1.45 1.71E−74 1.04E−72
RPL37A −1.45 3.14E−201 1.14E−198
ARRDC3 −1.45 2.82E−84 2.26E−82
NAE1 −1.45 1.38E−78 9.72E−77
MYZAP −1.45 7.55E−09 2.60E−08
FBXO2 −1.44 3.57E−23 3.45E−22
C1QL1 −1.44 1.45E−18 1.05E−17
FDPS −1.44 1.12E−208 4.30E−206
FER1L4 −1.44 2.19E−34 3.63E−33
TMEM8B −1.44 2.90E−24 3.00E−23
THOC6 −1.44 1.49E−31 2.17E−30
DMPK −1.43 9.94E−26 1.1 IE−24
RNF181 −1.43 1.88E−42 4.26E−41
GUK1 −1.43 3.52E−94 3.37E−92
GHDC −1.43 2.52E−15 1.47E−14
GRAMD1A −1.43 1.76E−70 9.52E−69
SYTL2 −1.43 3.67E−25 3.98E−24
LEPR −1.43 7.79E−22 7.01E−21
FLJ22184 −1.43 9.59E−18 6.57E−17
EXOSC9 −1.42 5.87E−47 1.59E−45
MMAB −1.42 2.1 IE−37 4.00E−36
KRT86 −1.42 1.20E−05 2.96E−05
ABHD1 −1.42 7.52E−08 2.34E−07
HOOK2 −1.42 1.59E−22 1.48E−21
PCSK4 −1.42 1.40E−10 5.56E−10
TMC6 −1.42 1.82E−28 2.31E−27
GDPD1 −1.42 6.19E−06 1.57E−05
LRRC23 −1.42 5.41E−11 2.25E−10
PION −1.42 3.83E−12 1.75E−11
BCL7C −1.42 9.48E−37 1.73E−35
YPEL3 −1.41 2.79E−10 1.08E−09
RAD51B −1.41 7.17E−15 4.03E−14
ANXA4 −1.41 3.39E−64 1.55E−62
B4GALNT4 −1.41 8.74E−13 4.18E−12
COX7B −1.41 1.11E−66 5.56E−65
PRKCZ −1.41 1.76E−15 1.03E−14
RAB4B −1.41 2.43E−21 2.10E−20
C4orf34 −1.40 1.44E−38 2.81E−37
STXIO −1.40 2.42E−15 1.41E−14
CRELD2 −1.40 5.50E−24 5.57E−23
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Gene symbol logFC P value FDR
ATP5E −1.39 6.27E−93 5.87E−91
ESD −1.39 1.48E−75 9.39E−74
MIA-RAB4B −1.39 1.84E−21 1.61E−20
NDUFA13 −1.39 5.54E−58 2.17E−56
SNX14 −1.39 3.32E−75 2.09E−73
MRPL13 −1.39 2.86E−44 6.97E−43
PTPRH −1.39 7.14E−18 4.93E−17
BBS5 −1.39 2.36E−32 3.55E−31
LMBRD1 −1.38 4.17E−25 4.50E−24
IQCH −1.38 4.75E−08 1.51E−07
LMTK3 −1.38 4.13E−14 2.19E−13
MIR497HG −1.38 6.24E−12 2.81E−11
C6orf70 −1.38 3.13E−25 3.41E−24
FGGY −1.38 5.12E−07 1.46E−06
UNC5CL −1.38 1.66E−08 5.52E−08
DUT −1.38 8.03E−114 1.13E−111
P2RX4 −1.38 2.17E−20 1.76E−19
HHIPL2 −1.38 4.20E−06 1.09E−05
COX5A −1.38 3.09E−79 2.21E−77
CKLF −1.37 6.08E−34 9.94E−33
CRYZL1 −1.37 7.16E−27 8.45E−26
GSTM4 −1.37 6.05E−20 4.80E−19
DNAH14 −1.37 3.44E−11 1.45E−10
TCTN1 −1.37 6.80E−12 3.05E−11
CBX3P2 −1.36 2.01E−06 5.42E−06
PTH1R −1.36 0.000133911 0.000291689
SEMA6C −1.36 2.31E−09 8.29E−09
PIR −1.36 2.10E−31 3.03E−30
DRAP1 −1.36 2.70E−101 2.90E−99
SCP2 −1.36 1.15E−12 5.47E−12
GMDS −1.36 8.89E−18 6.10E−17
FRG1B −1.36 9.55E−13 4.56E−12
DECR1 −1.35 4.15E−35 7.08E−34
CTAGE5 −1.35 4.25E−40 8.82E−39
NPM3 −1.35 1.82E−40 3.82E−39
AASS −1.35 2.75E−05 6.49E−05
ZC3H6 −1.35 1.1 IE−29 1.48E−28
C6orf203 −1.35 2.06E−08 6.82E−08
ADAMTS13 −1.35 1.19E−11 5.23E−11
UBXN11 −1.35 2.01E−06 5.42E−06
C10orf54 −1.35 3.00E−63 1.32E−61
LSS −1.35 7.02E−41 1.49E−39
KLC4 −1.35 7.74E−09 2.66E−08
ITGB3BP −1.35 6.76E−11 2.78E−10
TKTL1 −1.35 2.72E−12 1.26E−11
C10orf55 −1.34 1.16E−63 5.16E−62
CRELD1 −1.34 1.99E−20 1.62E−19
ADSSL1 −1.34 2.20E−21 1.91E−20
ALKBH7 −1.34 1.62E−27 1.97E−26
AIFM3 −1.34 5.13E−07 1.47E−06
LLGL2 −1.34 2.44E−09 8.76E−09
SLC27A1 −1.34 1.99E−13 9.99E−13
ZBTB8OS −1.34 5.50E−20 4.37E−19
Table 3 continued
Gene symbol logFC P value FDR
ANKRD13D −1.34 7.36E−25 7.86E−24
C6orf57 −1.34 3.31E−07 9.64E−07
GCAT −1.33 8.16E−10 3.04E−09
TEX9 −1.33 1.32E−05 3.23E−05
MAP2K5 −1.33 9.00E−11 3.66E−10
SLC27A2 −1.33 2.27E−21 1.97E−20
LTBP3 −1.33 2.53E−43 5.95E−42
LOC100287559 −1.33 4.09E−05 9.47E−05
IFITM10 −1.33 9.64E−09 3.28E−08
CRYL1 −1.33 6.22E−10 2.34E−09
USH1C −1.33 4.48E−09 1.57E−08
ZC3H12D −1.33 0.000330901 0.000684453
ERI2 −1.32 7.33E−09 2.53E−08
TBX6 −1.32 0.000899671 0.001760238
WBSCR22 −1.32 1.53E−55 5.53E−54
GNB2L1 −1.32 2.65E−272 1.40E−269
LOC100131089 −1.32 3.24E−08 1.05E−07
EGFL7 −1.32 8.28E−37 1.52E−35
PIM3 −1.31 6.31E−67 3.18E−65
NUCB1 −1.31 1.86E−79 1.34E−77
FDXR −1.31 1.08E−19 8.38E−19
EMID1 −1.31 2.72E−09 9.72E−09
PIBF1 −1.31 2.54E−16 1.58E−15
HIBCH −1.30 1.13E−15 6.72E−15
RPS7 −1.30 4.23E−158 1.05E−155
BIK −1.30 5.76E−06 1.47E−05
TCP11L2 −1.30 9.98E−07 2.77E−06
TSNAX-DISC1 −1.30 6.33E−22 5.72E−21
OMA1 −1.30 1.35E−25 1.50E−24
LOC100506990 −1.30 3.51E−09 1.24E−08
TSTD1 −1.30 7.46E−28 9.23E−27
KISS1R −1.30 0.000386067 0.000792495
BCKDHA −1.29 2.10E−43 4.98E−42
B9D1 −1.29 3.14E−13 1.56E−12
ZNF695 −1.29 8.45E−10 3.14E−09
TMEM63B −1.29 2.19E−69 1.17E−67
MOSPD3 −1.29 8.70E−19 6.37E−18
RNASE4 −1.29 2.00E−27 2.42E−26
UGGT2 −1.29 6.04E−21 5.06E−20
SEMA3F −1.29 2.32E−19 1.77E−18
RPS24 −1.29 6.92E−214 2.83E−211
DAK −1.29 4.77E−62 2.04E−60
LOC100130691 −1.29 0.000198722 0.0004236
CTU2 −1.29 1.68E−13 8.48E−13
PLD3 −1.29 7.26E−45 1.81E−43
RHOV −1.29 2.06E−15 1.20E−14
CHPT1 −1.29 5.19E−67 2.64E−65
ACSM3 −1.29 3.03E−11 1.29E−10
RPS25 −1.28 4.03E−185 1.31E−182
OASL −1.28 2.48E−11 1.06E−10
RPLP1 −1.28 7.23E−219 3.05E−216
C19orf79 −1.28 2.43E−11 1.04E−10
IL20RB −1.28 1.18E−09 4.32E−09
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Gene symbol logFC P value FDR
CACNG6 −1.28 1.23E−05 3.02E−05
TBCE −1.28 1.40E−28 1.78E−27
FBXO16 −1.28 0.00019181 0.000409623
LOC100505549 −1.28 9.29E−06 2.31E−05
LOC100507218 −1.28 0.000213956 0.000453549
TLR5 −1.28 0.000112273 0.000247109
EML2 −1.28 1.54E−14 8.42E−14
NPM1 −1.28 3.12E−138 6.48E−136
GAA −1.28 1.30E−32 1.99E−31
NKD2 −1.28 4.23E−10 1.61E−09
CRIP2 −1.28 8.19E−11 3.34E−10
LOC100132891 −1.27 6.71E−07 1.89E−06
ALG5 −1.27 2.16E−16 1.35E−15
PXK −1.27 1.02E−14 5.67E−14
ADA −1.27 6.1 IE−14 3.20E−13
GALE −1.27 3.38E−45 8.55E−44
PHGDH −1.27 3.96E−113 5.44E−111
CREG2 −1.27 0.000426556 0.000871508
MSLN −1.27 2.53E−19 1.93E−18
GDPD5 −1.27 1.22E−12 5.80E−12
ITGA7 −1.27 5.07E−06 1.30E−05
LIG1 −1.27 1.36E−27 1.66E−26
LRTOMT −1.26 4.37E−06 1.13E−05
C17orf49 −1.26 1.37E−44 3.39E−43
HMGN5 −1.26 5.93E−07 1.69E−06
LOC100505624 −1.26 4.04E−10 1.55E−09
CATSPER1 −1.25 0.000949224 0.00184719
TLE2 −1.25 2.35E−16 1.46E−15
CES3 −1.25 5.98E−07 1.70E−06
TTC35 −1.25 7.52E−30 1.01E−28
C6orf72 −1.25 2.65E−33 4.23E−32
RPS19 −1.25 1.01E−168 2.84E−166
EVI5L −1.25 3.82E−23 3.68E−22
LOC81691 −1.25 7.76E−11 3.17E−10
PLEKHH3 −1.25 5.91E−39 1.17E−37
LOC100507501 −1.24 1.34E−06 3.67E−06
SLC25A5-AS1 −1.24 2.22E−20 1.80E−19
RPS8 −1.24 1.41E−201 5.25E−199
PPP1R7 −1.24 3.54E−37 6.58E−36
MAGED2 −1.24 4.04E−41 8.64E−40
CSTF3 −1.24 1.10E−12 5.24E−12
LINC00467 −1.24 1.39E−17 9.42E−17
MAD2L2 −1.24 4.26E−29 5.54E−28
PCCB −1.24 2.05E−53 6.87E−52
SEZ6L2 −1.24 1.72E−27 2.09E−26
FKBP2 −1.24 8.99E−30 1.20E−28
DOCK6 −1.24 4.80E−35 8.13E−34
WIPI1 −1.24 2.07E−06 5.57E−06
ECH1 −1.23 5.12E−76 3.32E−74
OCEL1 −1.23 7.19E−14 3.74E−13
ZNF385C −1.23 2.37E−06 6.31E−06
ATP8B3 −1.23 6.42E−24 6.47E−23
PAFAH1B2 −1.23 8.05E−25 8.57E−24
Table 3 continued
Gene symbol logFC P value FDR
TM4SF19-TCTEX1D −1.23 1.23E−05 3.02E−05
SRPX −1.23 5.84E−11 2.42E−10
SLC39A11 −1.23 3.03E−21 2.60E−20
TMEM41B −1.22 5.82E−09 2.02E−08
PADI2 −1.22 3.51E−11 1.48E−10
STX4 −1.22 8.39E−28 1.03E−26
MAP4K2 −1.22 1.86E−20 1.51E−19
PXMP4 −1.22 2.50E−07 7.39E−07
TCIRG1 −1.22 2.38E−41 5.15E−40
SERPING1 −1.22 8.23E−08 2.55E−07
IFI35 −1.22 4.92E−13 2.41E−12
DPY19L1P1 −1.22 3.99E−07 1.15E−06
MAN2B1 −1.22 5.94E−48 1.67E−46
FAF1 −1.22 5.28E−51 1.65E−49
ZDHHC1 −1.22 2.34E−06 6.25E−06
NAAA −1.21 4.63E−11 1.93E−10
EFCAB11 −1.21 4.21E−05 9.73E−05
HSCB −1.21 1.67E−12 7.85E−12
FBXW9 −1.21 2.21E−05 5.28E−05
ZNF467 −1.21 1.19E−09 4.36E−09
ILVBL −1.21 1.32E−44 3.28E−43
SDR16C5 −1.21 4.72E−17 3.09E−16
IQGAP2 −1.21 6.21E−07 1.76E−06
SRGAP3 −1.21 2.76E−05 6.50E−05
EGF −1.21 0.000108319 0.000238866
ERGIC3 −1.21 2.97E−63 1.31E−61
CYFIP2 −1.21 3.35E−14 1.79E−13
BCAS3 −1.21 5.34E−23 5.11E−22
DOCK11 −1.21 3.15E−11 1.33E−10
SLC37A1 −1.21 1.67E−07 5.02E−07
HSD17B4 −1.21 1.16E−54 4.10E−53
NT5M −1.21 7.71E−05 0.000172918
SERINC5 −1.20 2.82E−06 7.46E−06
CCDC85B −1.20 9.58E−95 9.54E−93
ALDH7A1 −1.20 1.18E−61 5.00E−60
OPLAH −1.20 1.60E−21 1.41E−20
ASNS −1.20 4.29E−106 5.17E−104
KIFAP3 −1.20 4.03E−26 4.60E−25
C1R −1.20 2.83E−07 8.29E−07
FRY −1.20 0.000920901 0.001797881
ANO9 −1.20 7.19E−07 2.02E−06
BCAM −1.20 7.19E−33 1.1 IE−31
MED30 −1.20 1.06E−13 5.46E−13
LOC100127983 −1.20 6.85E−06 1.73E−05
CBS −1.20 1.10E−55 4.00E−54
PNPLA2 −1.19 7.09E−37 1.30E−35
C1QL4 −1.19 1.08E−07 3.32E−07
LOC100129716 −1.19 0.000363791 0.000749078
ANKRD36BP2 −1.19 0.000287863 0.000599766
LCMT1 −1.19 7.16E−13 3.45E−12
SHF −1.19 3.46E−06 9.04E−06
RABGGTA −1.19 2.76E−10 1.07E−09
ANKRA2 −1.19 4.84E−15 2.76E−14
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Gene symbol logFC P value FDR
SYT12 −1.19 8.47E−20 6.64E−19
PYROXD2 −1.19 2.34E−06 6.25E−06
COPG2 −1.19 2.42E−35 4.16E−34
RAP1GAP −1.19 1.26E−08 4.24E−08
LOC728743 −1.18 2.13E−05 5.11E−05
SRI −1.18 5.42E−43 1.27E−41
DDX43 −1.18 2.82E−23 2.74E−22
PRIM1 −1.18 1.39E−29 1.85E−28
FAM125A −1.18 2.67E−16 1.65E−15
HCFC1R1 −1.18 6.80E−52 2.20E−50
THBS3 −1.18 3.57E−18 2.51E−17
C15orf48 −1.18 6.58E−30 8.85E−29
C11orf54 −1.18 7.03E−18 4.86E−17
CTSF −1.18 5.63E−26 6.40E−25
CDH3 −1.18 4.89E−59 1.96E−57
ULK4 −1.18 0.000777011 0.001532576
C1S −1.17 6.98E−05 0.00015741
VSIG1 −1.17 0.000372512 0.00076579
MED25 −1.17 6.05E−19 4.47E−18
AIG1 −1.17 7.65E−17 4.93E−16
VAV1 −1.17 2.41E−14 1.30E−13
PPA2 −1.17 1.32E−33 2.13E−32
FAM98C −1.17 5.33E−05 0.000121815
FCGRT −1.17 1.69E−26 1.95E−25
EXOSC8 −1.17 1.71E−25 1.88E−24
TMEM160 −1.17 1.88E−11 8.15E−11
SREBF1 −1.17 2.51E−32 3.78E−31
Clorf172 −1.17 8.99E−06 2.24E−05
MSI2 −1.17 1.73E−11 7.52E−11
IMPA2 −1.17 6.70E−36 1.17E−34
IGFBP6 −1.17 1.04E−18 7.55E−18
EIF2D −1.17 7.55E−48 2.12E−46
LTA4H −1.16 7.60E−76 4.88E−74
ASL −1.16 7.72E−28 9.53E−27
ETHE1 −1.16 1.72E−23 1.69E−22
RPH3AL −1.16 4.72E−21 3.99E−20
KLHDC2 −1.16 2.62E−74 1.59E−72
FAM171A2 −1.16 2.02E−09 7.29E−09
IFT88 −1.16 2.41E−07 7.15E−07
SIGIRR −1.16 1.53E−05 3.72E−05
SUGT1 −1.16 1.60E−19 1.23E−18
TXNIP −1.16 3.34E−07 9.72E−07
GTF2H2D −1.16 0.000102722 0.000227077
REEP6 −1.15 1.93E−18 1.38E−17
AAAS −1.15 5.67E−34 9.29E−33
CDKL2 −1.15 0.000611109 0.001221929
MRC2 −1.15 2.67E−32 4.02E−31
RPN2 −1.15 4.07E−177 1.26E−174
FN3K −1.15 5.62E−11 2.33E−10
ST14 −1.15 5.82E−11 2.41E−10
GRAPL −1.15 0.002321122 0.004253204
CUEDC2 −1.15 2.06E−28 2.59E−27
IFI30 −1.15 1.81E−08 6.01E−08
Table 3 continued
Gene symbol logFC P value FDR
C9orf46 −1.15 1.24E−12 5.89E−12
ABCA5 −1.15 1.85E−07 5.53E−07
RPGR −1.15 2.48E−07 7.34E−07
PKN1 −1.15 2.23E−84 1.80E−82
ATG16L2 −1.15 1.06E−06 2.95E−06
WBSCR27 −1.15 3.77E−06 9.80E−06
LRRC45 −1.14 1.24E−17 8.40E−17
PTMS −1.14 1.81E−79 1.31E−77
CKLF-CMTM1 −1.14 1.06E−16 6.72E−16
BTC −1.14 3.10E−05 7.27E−05
TNFSF12-TNFS”13 −1.14 7.55E−19 5.53E−18
PREX1 −1.14 4.53E−09 1.58E−08
FGD3 −1.14 7.45E−05 0.000167354
PCIF1 −1.14 2.14E−34 3.56E−33
CALB2 −1.14 3.17E−06 8.33E−06
PTGES −1.14 3.74E−21 3.18E−20
HES7 −1.13 0.003803794 0.00674057
FGFR4 −1.13 8.06E−24 8.07E−23
NFKBID −1.13 0.00094651 0.001842867
BMP1 −1.13 1.37E−31 2.00E−30
MSI1 −1.13 0.002464428 0.004500152
RPS6KB2 −1.13 2.74E−20 2.21E−19
KCTD19 −1.13 3.06E−06 8.06E−06
CCDC88B −1.13 1.55E−11 6.73E−11
SCNN1A −1.13 4.23E−35 7.21E−34
POMGNT1 −1.13 8.85E−41 1.88E−39
HECTD2 −1.13 0.001588305 0.002987874
NUP107 −1.13 2.10E−54 7.31E−53
CXCL16 −1.13 5.14E−12 2.33E−11
GAPDHS −1.13 0.001914622 0.003556771
CDC42BPG −1.13 3.79E−08 1.22E−07
MLXIPL −1.12 6.00E−06 1.53E−05
IFI27L1 −1.12 1.31E−13 6.68E−13
ABCA7 −1.12 5.03E−32 7.44E−31
CREB3L4 −1.12 8.76E−17 5.61E−16
COPE −1.12 1.68E−31 2.44E−30
PEMT −1.12 4.08E−08 1.31E−07
PKN3 −1.12 2.05E−12 9.57E−12
UQCRC1 −1.12 3.06E−84 2.42E−82
DNAJC4 −1.12 2.58E−15 1.50E−14
FAM175A −1.12 3.67E−05 8.54E−05
FIBP −1.12 1.34E−48 3.86E−47
KCNN1 −1.12 1.14E−05 2.82E−05
RQCD1 −1.12 5.66E−19 4.19E−18
JUNB −1.11 9.88E−50 2.95E−48
ASPSCR1 −1.11 5.66E−13 2.76E−12
QPCTL −1.11 4.68E−25 5.04E−24
CD9 −1.11 3.02E−94 2.91E−92
SH2B2 −1.11 6.68E−05 0.000151083
SSR4 −1.11 1.05E−19 8.16E−19
NDUFA2 −1.11 8.18E−19 5.99E−18
ALPK1 −1.11 1.89E−16 1.19E−15
GFM2 −1.11 1.22E−54 4.29E−53
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Gene symbol logFC P value FDR
GPCPD1 −1.11 8.79E−19 6.43E−18
NDRG2 −1.11 1.37E−06 3.74E−06
PRSS22 −1.11 0.002080435 0.003844256
MST1P9 −1.11 0.002266527 0.004161499
TRIM9 −1.11 0.000204924 0.000435644
ATP2A3 −1.11 4.09E−09 1.44E−08
TMEM161A −1.11 2.06E−12 9.63E−12
ING4 −1.11 5.53E−08 1.75E−07
METTL5 −1.11 9.00E−34 1.46E−32
IFT74 −1.11 2.99E−11 1.27E−10
GALT −1.10 9.23E−14 4.76E−13
ZCWPW2 −1.10 2.10E−32 3.17E−31
USH1G −1.10 0.002619829 0.004769462
FAM162A −1.10 1.90E−18 1.36E−17
BCL3 −1.10 3.72E−46 9.84E−45
TSPAN1 −1.10 9.28E−12 4.1 IE−11
SIPA1 −1.10 2.57E−25 2.80E−24
WDR27 −1.10 8.86E−07 2.47E−06
LOC678655 −1.10 2.98E−09 1.06E−08
MATN2 −1.10 3.00E−17 1.98E−16
SERPINI1 −1.10 7.67E−07 2.15E−06
NPRL2 −1.10 8.74E−12 3.88E−11
IRF6 −1.10 3.53E−11 1.49E−10
C17orf57 −1.10 9.25E−06 2.30E−05
HSPB11 −1.10 2.47E−11 1.06E−10
LOXL2 −1.10 2.56E−119 4.1 IE−117
GATS −1.10 3.88E−07 1.12E−06
POLD1 −1.10 3.61E−38 6.98E−37
KREMEN2 −1.10 0.000906345 0.001771925
SH3YL1 −1.09 7.15E−18 4.93E−17
HEXDC −1.09 3.33E−08 1.08E−07
CHIC2 −1.09 5.08E−05 0.000116308
FLJ39051 −1.09 0.000444045 0.000904903
ALKBH6 −1.09 4.88E−09 1.70E−08
MAGOH −1.09 1.09E−14 6.06E−14
LOC100505783 −1.09 1.52E−05 3.70E−05
C16orf62 −1.09 1.35E−24 1.42E−23
GAL3ST1 −1.09 0.004091279 0.00721967
ZNF670-ZNF695 −1.09 6.71E−07 1.89E−06
UGCG −1.09 2.19E−49 6.44E−48
AS3MT −1.09 0.000326442 0.000675804
GRTP1 −1.09 2.37E−05 5.64E−05
AQP3 −1.09 3.02E−08 9.82E−08
TMEM45B −1.09 7.62E−14 3.95E−13
ZP3 −1.09 2.43E−08 7.96E−08
AP4M1 −1.09 8.43E−09 2.89E−08
PLD1 −1.09 2.70E−06 7.14E−06
CCBL2 −1.09 2.76E−20 2.23E−19
NR4A1 −1.08 4.86E−21 4.10E−20
BRE −1.08 1.97E−33 3.15E−32
PCYOX1L −1.08 3.06E−15 1.77E−14
KIAA1456 −1.08 4.80E−05 0.000110264
AARS −1.08 1.30E−192 4.43E−190
Table 3 continued
Gene symbol logFC P value FDR
MRPL47 −1.08 2.55E−16 1.58E−15
ERP44 −1.08 4.10E−42 9.20E−41
ARHGEF16 −1.08 5.13E−13 2.51E−12
TP53TG1 −1.08 1.83E−05 4.40E−05
FA2H −1.08 1.77E−08 5.89E−08
ADAM15 −1.07 4.71E−73 2.73E−71
STAG3 −1.07 0.005718352 0.00986248
PTK2B −1.07 4.07E−14 2.16E−13
NSMCE1 −1.07 5.38E−18 3.74E−17
ATXNIO −1.07 9.31E−82 6.97E−80
CCDC53 −1.07 3.48E−15 2.01E−14
MIPEP −1.07 4.92E−10 1.87E−09
TNFAIP2 −1.07 1.57E−146 3.48E−144
PSMA5 −1.07 1.18E−41 2.60E−40
INSIG1 −1.07 8.19E−55 2.90E−53
KIAA1383 −1.07 4.15E−06 1.07E−05
SDC2 −1.07 3.27E−05 7.64E−05
COX5B −1.07 7.29E−32 1.08E−30
DTX4 −1.07 2.75E−06 7.28E−06
LOC100289495 −1.07 7.59E−05 0.000170296
BIN1 −1.07 8.92E−11 3.62E−10
CLDN7 −1.07 2.52E−17 1.68E−16
LMF1 −1.07 1.18E−05 2.90E−05
C11orf93 −1.07 0.000180253 0.000386051
C1RL −1.06 2.49E−30 3.42E−29
MTMR11 −1.06 8.82E−20 6.91E−19
CST6 −1.06 4.12E−16 2.53E−15
CRISPLD1 −1.06 1.71E−07 5.16E−07
PFKL −1.06 3.28E−73 1.92E−71
IER5L −1.06 1.03E−19 8.04E−19
NUDT17 −1.06 2.65E−07 7.80E−07
RABAC1 −1.06 9.34E−31 1.31E−29
ABCA2 −1.06 2.56E−49 7.50E−48
TRAP1 −1.06 1.61E−76 1.05E−74
BBS9 −1.06 1.98E−11 8.56E−11
MMP15 −1.06 3.72E−27 4.45E−26
SCPEP1 −1.06 4.13E−22 3.76E−21
TLL2 −1.06 4.28E−05 9.90E−05
VPS28 −1.06 3.44E−19 2.60E−18
TCN2 −1.06 9.31E−07 2.59E−06
HS1BP3 −1.06 5.55E−20 4.41E−19
HMG20B −1.06 9.18E−84 7.22E−82
FUCA1 −1.06 4.76E−18 3.32E−17
ARHGEF7 −1.05 1.63E−11 7.10E−11
WDR33 −1.05 6.18E−10 2.33E−09
SYT13 −1.05 0.004669962 0.008171303
C16orf13 −1.05 3.16E−24 3.26E−23
KTN1 −1.05 6.31E−91 5.75E−89
GPX4 −1.05 4.33E−82 3.26E−80
RPS16 −1.05 2.85E−107 3.46E−105
AGXT2L2 −1.05 1.67E−12 7.88E−12
TMEM141 −1.05 1.52E−18 1.09E−17
LAMP3 −1.05 4.66E−06 1.20E−05
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Gene symbol logFC P value FDR
CDKN1C −1.05 0.000424019 0.000866884
LOC100288846 −1.05 0.000988006 0.001917938
DHRS12 −1.05 0.008237024 0.013823818
ATP6AP1L −1.05 0.008191315 0.013754406
ERCC2 −1.05 4.13E−23 3.98E−22
FMO5 −1.05 0.008652057 0.014449416
ULK2 −1.05 8.06E−20 6.33E−19
SMARCD3 −1.05 2.06E−08 6.82E−08
PHYHD1 −1.05 4.25E−11 1.78E−10
C10orf11 −1.05 0.003354135 0.006000913
KRTCAP3 −1.05 0.000203547 0.000433154
SRP54 −1.05 2.70E−88 2.32E−86
IMMP2L −1.04 2.06E−07 6.13E−07
CARS −1.04 3.50E−44 8.52E−43
RPL24 −1.04 5.98E−76 3.86E−74
GSN −1.04 3.51E−17 2.31E−16
BAI2 −1.04 9.31E−16 5.58E−15
WDR18 −1.04 1.17E−46 3.16E−45
ZC4H2 −1.04 0.009400904 0.015597066
EIF3M −1.04 4.78E−59 1.93E−57
SLC25A42 −1.04 7.39E−08 2.30E−07
MTHFR −1.04 2.62E−10 1.02E−09
ABCG2 −1.04 0.003349706 0.005994684
NR1H3 −1.04 0.000505923 0.001023253
PAAF1 −1.04 2.18E−21 1.90E−20
GSTK1 −1.04 1.65E−37 3.13E−36
DEPDC4 −1.04 0.000125031 0.000273146
ZNF396 −1.04 2.31E−05 5.51E−05
BHLHE40 −1.04 2.30E−66 1.15E−64
TECPR1 −1.04 3.48E−13 1.72E−12
AMN1 −1.04 1.59E−07 4.80E−07
NTPCR −1.04 3.26E−21 2.79E−20
MVD −1.04 5.49E−40 1.13E−38
RRAS −1.04 1.37E−24 1.44E−23
LOC144481 −1.03 0.001555384 0.00293074
SURF1 −1.03 1.48E−25 1.64E−24
MFF −1.03 1.03E−98 1.09E−96
MAGED1 −1.03 3.74E−72 2.11E−70
TBL3 −1.03 7.98E−25 8.51E−24
DYX1C1 −1.03 0.000142357 0.000309076
SLC16A5 −1.03 2.35E−23 2.30E−22
GPRIN2 −1.03 1.03E−10 4.17E−10
LOC100130015 −1.03 2.39E−07 7.07E−07
DDX60 −1.03 0.000267213 0.000559136
MITD1 −1.03 1.44E−11 6.27E−11
RBP1 −1.03 0.006467371 0.011039757
TBCA −1.03 5.18E−33 8.15E−32
ICAM5 −1.03 5.23E−14 2.75E−13
TNFRSF10C −1.03 0.00023491 0.000494816
CPE −1.03 7.1 IE−14 3.70E−13
ANK2 −1.03 3.67E−11 1.54E−10
C22orf26 −1.03 0.000452354 0.000920647
SNX2 −1.03 6.73E−33 1.04E−31
Table 3 continued
Gene symbol logFC P value FDR
ANXA3 −1.03 1.06E−78 7.48E−77
C15orf58 −1.02 0.00133034 0.002534258
RBX1 −1.02 1.31E−21 1.16E−20
ABCD1 −1.02 4.71E−08 1.50E−07
P4HA3 −1.02 0.000276213 0.00057711
KRBA2 −1.02 0.004111753 0.007253308
GLS2 −1.02 0.000259768 0.000544639
ENDOG −1.02 5.93E−08 1.87E−07
COX7C −1.02 6.09E−67 3.08E−65
C8orf59 −1.02 2.88E−20 2.32E−19
RAB11FIP4 −1.02 6.08E−09 2.11E−08
CDKL1 −1.02 8.11E−06 2.03E−05
LOC100133957 −1.02 0.001919501 0.003564787
DENND1A −1.02 5.20E−33 8.18E−32
TRAM1 −1.02 1.47E−76 9.69E−75
UPK3B −1.02 9.22E−07 2.56E−06
ANKRD29 −1.02 1.13E−27 1.38E−26
CHMP5 −1.02 7.09E−56 2.61E−54
CCDC125 −1.02 4.05E−07 1.17E−06
MEF2BNB-MEF2B −1.01 0.000476068 0.000966579
PTPRE −1.01 2.62E−47 7.25E−46
MAGIX −1.01 0.012672093 0.020531485
MDP1 −1.01 0.000316356 0.000656213
SEMA4G −1.01 2.18E−21 1.90E−20
TRMT11 −1.01 7.49E−10 2.80E−09
TNFRSF9 −1.01 0.001333696 0.002540269
AMZ2P1 −1.01 1.77E−07 5.32E−07
C7orf10 −1.01 0.000709162 0.001406426
PRPF40B −1.01 5.32E−24 5.39E−23
NCOA7 −1.01 8.97E−40 1.84E−38
MPND −1.01 0.000182363 0.000390505
C17orf28 −1.01 1.33E−07 4.04E−07
PFDN5 −1.01 1.94E−57 7.44E−56
VWA1 −1.01 1.13E−18 8.22E−18
VPS33B −1.01 4.79E−11 2.00E−10
PHYHIP −1.00 2.49E−07 7.35E−07
SUSD2 −1.00 2.55E−29 3.35E−28
CCNA1 −1.00 1.64E−08 5.47E−08
GAMT −1.00 4.53E−10 1.72E−09
SLC44A2 −1.00 2.72E−41 5.85E−40
ODF2L −1.00 2.38E−16 1.48E−15
HIST1H1C −1.00 2.07E−43 4.93E−42
TAF10 −1.00 6.64E−28 8.23E−27
AKT3 −1.00 7.55E−14 3.92E−13
MACROD2 −1.00 0.008868792 0.014782098
ADAM23 −1.00 1.90E−08 6.31E−08
COQ6 −1.00 2.59E−13 1.29E−12
DLEU2 −1.00 0.005572257 0.009628891
CAT −1.00 1.55E−30 2.14E−29
MSMO1 −1.00 4.14E−33 6.57E−32
LOC100506334 −1.00 3.11E−06 8.17E−06
TARS2 −1.00 2.70E−38 5.25E−37
P4HTM −1.00 1.17E−15 6.93E−15
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Table 3 continued
Gene symbol logFC P value FDR
EBF4 −1.00 0.001175315 0.002258326
ARHGEF26-AS1 −1.00 0.000118469 0.000259887
OSGEPL1 −1.00 1.23E−11 5.41E−11
PPFIA3 −1.00 2.52E−05 5.96E−05
C19orf71 −1.00 1.03E−05 2.56E−05
CECR2 −1.00 0.000117675 0.000258236
NAT14 −0.99 1.20E−13 6.15E−13
FADS2 −0.99 2.47E−79 1.77E−77
CALCOCOl −0.99 3.84E−18 2.69E−17
APOL1 −0.99 0.000590629 0.001183409
ITFG3 −0.99 2.53E−39 5.08E−38
KDELC1 −0.99 1.11E−06 3.05E−06
RPL3 −0.99 1.72E−158 4.35E−156
PLCL2 0.99 1.02E−08 3.47E−08
AOC2 0.99 5.20E−07 1.48E−06
ZBTB2 0.99 3.55E−64 1.61E−62
LOC387647 0.99 2.94E−28 3.68E−27
GDF11 0.99 1.84E−42 4.17E−41
LOC100130992 0.99 6.14E−14 3.21E−13
ZNF407 0.99 1.38E−21 1.22E−20
LOC100288615 0.99 2.15E−11 9.26E−11
TEX15 0.99 1.21E−49 3.59E−48
PMS2P5 0.99 2.22E−10 8.68E−10
TSPYL4 1.00 3.02E−31 4.33E−30
FICD 1.00 4.01E−07 1.16E−06
ZNF587 1.00 3.63E−30 4.94E−29
ANKRD50 1.00 4.80E−50 1.46E−48
NR5A2 1.00 3.61E−06 9.42E−06
ZBTB40 1.00 9.91E−30 1.32E−28
SLAMF7 1.00 1.57E−11 6.83E−11
LOC100129046 1.00 2.73E−07 8.03E−07
PHLPP2 1.00 2.77E−38 5.37E−37
ZNF267 1.00 7.57E−20 5.95E−19
FLNC 1.00 9.43E−158 2.29E−155
ZNF850 1.00 1.62E−14 8.85E−14
HOXB6 1.00 7.96E−27 9.37E−26
RNF34 1.00 6.70E−44 1.61E−42
FOXO3 1.01 5.30E−30 7.17E−29
HUS1 1.01 1.05E−20 8.65E−20
ZNF185 1.01 1.74E−82 1.33E−80
GJA1 1.01 6.19E−16 3.75E−15
AP1S2 1.01 1.54E−19 1.19E−18
TUBB2A 1.01 9.33E−18 6.40E−17
IL16 1.01 0.000167472 0.000360202
ZNF799 1.02 1.30E−09 4.76E−09
LOC100505648 1.02 0.000565896 0.001136915
FAM160A1 1.02 0.004606923 0.008071049
KCTD7 1.02 8.21E−16 4.95E−15
ZNF271 1.02 7.41E−78 5.06E−76
LOC401588 1.02 7.86E−08 2.44E−07
EIF5A 1.02 1.72E−190 5.72E−188
ABHD16B 1.02 1.13E−13 5.79E−13
NBPF15 1.03 4.54E−51 1.43E−49
Table 3 continued
Gene symbol logFC P value FDR
LOC283922 1.03 0.001810781 0.003376264
GDAP1 1.03 2.93E−52 9.56E−51
KANSL1 1.03 2.80E−09 9.97E−09
HOXB5 1.03 4.62E−16 2.83E−15
LRRC37A4P 1.03 4.01E−19 3.00E−18
RCBTB2 1.04 0.003040041 0.005483952
MYB 1.04 7.95E−05 0.000177891
SLC35F3 1.04 4.08E−27 4.87E−26
LOC100287314 1.04 0.00752343 0.012712245
ZNF33A 1.04 7.90E−65 3.71E−63
TARDBP 1.04 2.43E−135 4.87E−133
FLJ42627 1.04 3.98E−10 1.52E−09
ZNF239 1.04 4.56E−32 6.76E−31
FAM86DP 1.04 1.66E−10 6.54E−10
IL1RL1 1.04 1.54E−08 5.17E−08
ZNF655 1.05 2.40E−34 3.98E−33
ZNF114 1.05 3.01E−18 2.13E−17
FAM35A 1.05 9.15E−46 2.38E−44
SIX2 1.05 0.000341596 0.000705559
ETS1 1.05 3.20E−96 3.24E−94
ERVK13-1 1.05 7.87E−08 2.45E−07
LOC100288123 1.05 0.003598851 0.006403414
SPATA13 1.05 5.28E−19 3.92E−18
PTGER2 1.06 9.55E−10 3.53E−09
METTL12 1.06 1.30E−08 4.37E−08
GNB3 1.06 0.000318505 0.000659914
NOG 1.06 0.001463904 0.002772409
LOC100379224 1.06 1.78E−12 8.34E−12
ZNF514 1.06 2.92E−18 2.07E−17
LOC100506649 1.06 1.27E−46 3.41E−45
CHORDC1 1.07 1.72E−57 6.60E−56
CDKN1A 1.07 7.51E−66 3.68E−64
ARMCX4 1.07 1.38E−14 7.62E−14
NBPF1 1.07 1.78E−24 1.86E−23
TJP2 1.07 8.04E−145 1.75E−142
LOC147804 1.07 1.07E−13 5.51E−13
PRDM13 1.07 2.87E−07 8.40E−07
SON 1.07 2.20E−170 6.31E−168
EPHB2 1.07 6.87E−09 2.37E−08
POM121C 1.08 7.93E−52 2.55E−50
ZNF443 1.08 2.53E−07 7.47E−07
JRK 1.08 7.15E−24 7.18E−23
KBTBD8 1.08 0.000226507 0.000478711
ASB16 1.08 1.81E−06 4.90E−06
FAM86B1 1.08 4.25E−08 1.36E−07
CREB5 1.08 8.91E−16 5.35E−15
VAMP1 1.08 4.97E−14 2.62E−13
USP32P1 1.08 3.37E−24 3.47E−23
IRGQ 1.08 4.72E−37 8.74E−36
RPS26 1.09 8.51E−106 1.02E−103
CLCN4 1.09 2.07E−11 8.92E−11
DPY19L2 1.09 1.60E−06 4.36E−06
TMPPE 1.10 0.000159821 0.000344921
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Gene symbol logFC P value FDR
RP9P 1.10 1.53E−14 8.36E−14
ZNF600 1.10 2.10E−16 1.32E−15
C17orf51 1.10 5.46E−47 1.48E−45
ABL2 1.10 6.59E−118 1.02E−115
ZRSR2 1.11 1.52E−05 3.70E−05
ATAD3B 1.11 3.55E−17 2.34E−16
ZBTB26 1.11 5.88E−14 3.08E−13
LOC100527964 1.11 0.000167054 0.00035964
RASSFIO 1.11 0.001652544 0.003100419
WDR52 1.12 0.001376432 0.002616151
ENTPD7 1.12 2.86E−59 1.16E−57
KLHL21 1.12 1.76E−47 4.90E−46
SERPINB7 1.13 5.41E−06 1.39E−05
TFCP2L1 1.13 4.61E−16 2.82E−15
RFTN1 1.13 4.04E−18 2.83E−17
PTHLH 1.13 1.75E−07 5.26E−07
C10rf216 1.13 3.58E−29 4.66E−28
MGC57346 1.13 1.40E−09 5.11E−09
MALAT1 1.14 3.24E−113 4.51E−111
NSUN5P1 1.14 1.10E−06 3.03E−06
C3orf52 1.14 8.59E−13 4.12E−12
MRPS25 1.14 4.61E−67 2.35E−65
C11orf41 1.14 1.89E−08 6.29E−08
EPHA4 1.14 1.27E−05 3.12E−05
LOC283624 1.14 1.05E−22 9.88E−22
FRMD6 1.15 1.79E−118 2.83E−116
XRCC2 1.15 5.36E−36 9.41E−35
ATF5 1.15 7.98E−35 1.34E−33
NOV 1.15 0.000586861 0.00117642
RPL23AP64 1.15 0.000182902 0.00039146
FGF5 1.15 7.83E−05 0.00017528
DNAH17 1.16 5.10E−06 1.31E−05
PPARGC1B 1.16 8.77E−12 3.89E−11
PEA15 1.16 1.76E−127 3.19E−125
MIR22HG 1.16 1.55E−27 1.89E−26
LOC219731 1.16 5.88E−05 0.000133586
SLC7A2 1.16 4.67E−05 0.000107518
ZEB1 1.16 2.44E−37 4.58E−36
MOB3C 1.17 1.91E−22 1.77E−21
SBDSP1 1.17 6.56E−27 7.74E−26
LCAT 1.17 3.08E−08 9.99E−08
HBEGF 1.17 2.63E−45 6.70E−44
MGC70870 1.17 1.69E−109 2.14E−107
CDC42EP2 1.18 6.61E−33 1.03E−31
LOC440300 1.18 1.60E−20 1.31E−19
TMED10P1 1.19 1.35E−14 7.42E−14
B3GALT5 1.19 0.000161499 0.000348482
BMPER 1.19 4.12E−14 2.19E−13
HERC2P7 1.19 1.08E−15 6.44E−15
SEMA3A 1.20 3.81E−10 1.46E−09
HNRNPU-AS1 1.20 1.86E−28 2.35E−27
C20orf118 1.20 1.01E−08 3.43E−08
LOC154761 1.21 1.58E−05 3.84E−05
Table 3 continued
Gene symbol logFC P value FDR
BTBD6 1.21 3.31E−124 5.74E−122
ALG10 1.21 3.97E−15 2.28E−14
LINC00338 1.22 2.07E−17 1.38E−16
RPL23AP7 1.22 5.87E−08 1.85E−07
CLDN15 1.22 3.94E−17 2.60E−16
TUBA4A 1.22 3.74E−64 1.69E−62
ZNF860 1.22 8.13E−19 5.96E−18
NBPFIO 1.23 1.33E−13 6.78E−13
EFNB2 1.23 5.00E−20 3.98E−19
C15orf52 1.24 3.83E−77 2.56E−75
RRS1 1.24 1.88E−119 3.05E−117
OXTR 1.24 1.09E−16 6.95E−16
CRMP1 1.25 1.15E−06 3.18E−06
ZNF440 1.25 3.58E−18 2.52E−17
EIF4EBP3 1.26 0.000648201 0.001292417
DUSP7 1.26 1.51E−29 1.99E−28
EXOG 1.26 8.37E−22 7.50E−21
MAMLD1 1.27 1.94E−25 2.14E−24
SMPD3 1.27 6.68E−09 2.31E−08
PNN 1.28 1.20E−105 1.42E−103
PMEPA1 1.28 1.35E−87 1.14E−85
SCARF1 1.29 2.58E−10 1.00E−09
LOC100505815 1.29 1.06E−07 3.24E−07
FBXL19-AS1 1.29 1.55E−13 7.86E−13
HIST1H4H 1.29 1.12E−08 3.80E−08
TUBB 1.30 1.63E−74 9.98E−73
LOC100289230 1.30 0.000190102 0.000406114
FAM111B 1.30 2.83E−117 4.27E−115
ZNF33B 1.30 1.31E−57 5.07E−56
ZNF121 1.30 1.57E−28 1.99E−27
ZNF780A 1.30 1.31E−25 1.45E−24
NEFM 1.30 2.06E−10 8.07E−10
DGCR11 1.30 1.08E−13 5.52E−13
ST20 1.31 5.79E−08 1.83E−07
ADAM1 1.32 7.15E−10 2.68E−09
SRSF1 1.32 1.55E−170 4.54E−168
LOC642846 1.33 2.29E−09 8.22E−09
LOC730755 1.33 4.02E−07 1.16E−06
ZNF594 1.33 2.96E−18 2.10E−17
ITGA2 1.33 7.36E−102 8.02E−100
RRN3P3 1.33 4.14E−10 1.58E−09
MXD1 1.34 2.31E−28 2.90E−27
PKI55 1.35 3.94E−10 1.51E−09
LOC100507433 1.35 9.28E−07 2.58E−06
PPAPDC1A 1.35 5.00E−27 5.95E−26
PIGW 1.35 7.76E−78 5.28E−76
NBPF9 1.35 3.18E−46 8.45E−45
ZNF782 1.36 4.73E−11 1.97E−10
RRP7B 1.36 4.18E−08 1.33E−07
MICA 1.36 1.68E−22 1.56E−21
SCARNA12 1.36 4.69E−05 0.000108075
DDX12P 1.36 1.67E−09 6.07E−09
RPSAP9 1.36 5.75E−08 1.81E−07
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library were determined by the University of Missouri 
DNA core. Deep sequencing was performed by the MU 
DNA core using Illumina HiSeq 2000 following the 
Table 3 continued
Gene symbol logFC P value FDR
PLEKHM1 1.37 2.14E−08 7.05E−08
CLDN1 1.37 1.78E−123 2.99E−121
TUBB1 1.37 1.35E−07 4.10E−07
SERHL 1.37 2.41E−09 8.64E−09
YY2 1.38 1.99E−15 1.16E−14
LOC344595 1.38 8.64E−13 4.14E−12
LOC654342 1.39 1.44E−08 4.83E−08
HCN2 1.39 1.10E−05 2.71E−05
TSSK2 1.39 5.96E−06 1.52E−05
SERTAD4 1.40 4.02E−18 2.81E−17
PTGDR2 1.40 1.65E−14 8.98E−14
HTR7P1 1.40 5.99E−16 3.63E−15
C10rf63 1.41 2.97E−32 4.44E−31
OBFC2A 1.41 1.26E−72 7.20E−71
ICOSLG 1.41 3.58E−23 3.46E−22
PPP1R3E 1.42 8.05E−22 7.22E−21
F13A1 1.42 1.56E−21 1.37E−20
WASH1 1.43 1.32E−13 6.69E−13
GNRH1 1.43 7.51E−09 2.59E−08
TLR2 1.44 2.19E−07 6.50E−07
PXDN 1.45 2.57E−18 1.83E−17
LOX 1.45 4.42E−65 2.1 IE−63
EIF3C 1.46 6.70E−21 5.60E−20
EIF3CL 1.46 6.74E−21 5.62E−20
DHRS4L2 1.46 4.24E−11 1.78E−10
CD274 1.46 6.02E−65 2.85E−63
LOC646329 1.46 4.89E−07 1.40E−06
ZNF767 1.46 6.55E−20 5.19E−19
SPNS2 1.46 4.72E−21 3.99E−20
LOC401431 1.47 1.10E−13 5.62E−13
SHISA7 1.47 1.52E−07 4.60E−07
WASH3P 1.47 1.01E−15 6.05E−15
C12orf34 1.47 6.88E−13 3.32E−12
LOC728643 1.47 6.16E−10 2.32E−09
PI4KAP1 1.48 3.1 IE−15 1.80E−14
HSPA8 1.48 0 0
BCL2A1 1.48 1.71E−11 7.41E−11
ADAMTS6 1.49 3.58E−06 9.33E−06
SPIN2B 1.49 1.12E−09 4.12E−09
TUBAIB 1.49 4.03E−278 2.32E−275
TNFAIP3 1.50 3.05E−159 7.86E−157
CCDC39 1.50 3.75E−05 8.72E−05
WASH5P 1.51 3.91E−50 1.19E−48
SPHK1 1.52 4.08E−27 4.87E−26
ZNF417 1.53 1.87E−17 1.25E−16
LOC100289019 1.53 3.60E−10 1.38E−09
TUBA1C 1.54 0 0
BMS1P5 1.54 2.70E−06 7.16E−06
BMS1P1 1.54 2.71E−06 7.17E−06
SHISA9 1.54 1.40E−48 4.04E−47
SOX9 1.54 1.14E−50 3.52E−49
ENC1 1.55 3.65E−104 4.24E−102
PLEKHA8P1 1.55 4.63E−10 1.76E−09
Table 3 continued
Gene symbol logFC P value FDR
NEAT1 1.55 2.74E−226 1.24E−223
LOC100506123 1.55 6.41E−12 2.88E−11
LOC100506599 1.56 1.30E−08 4.37E−08
FOXO3B 1.56 4.19E−17 2.76E−16
PDIA3P 1.56 1.88E−19 1.44E−18
MMP1 1.56 6.14E−19 4.53E−18
FERMT1 1.57 9.62E−144 2.06E−141
NPTX2 1.57 2.39E−07 7.07E−07
MSTO2P 1.58 3.96E−15 2.27E−14
ZFP112 1.58 2.53E−18 1.80E−17
AFG3L1P 1.59 3.41E−74 2.05E−72
TFRC 1.60 1.56E−210 6.16E−208
SPRN 1.63 3.15E−21 2.70E−20
LOC100133091 1.64 4.17E−08 1.33E−07
GKN2 1.64 1.01E−19 7.88E−19
LOC100272217 1.64 8.20E−08 2.54E−07
LOC100132247 1.66 1.26E−11 5.53E−11
UBC 1.67 0 0
LOC440894 1.69 4.98E−07 1.42E−06
HERC2P2 1.70 1.86E−84 1.51E−82
CBWD2 1.70 2.67E−09 9.56E−09
DQX1 1.71 1.13E−10 4.53E−10
CHRM3 1.72 1.40E−14 7.68E−14
TMEM158 1.72 1.85E−29 2.44E−28
G0S2 1.73 4.26E−70 2.29E−68
LOC100288778 1.77 5.61E−13 2.74E−12
CCZ1 1.81 6.97E−29 9.02E−28
GPR89A 1.81 6.1 IE−21 5.12E−20
DOK3 1.83 1. OOE−10 4.05E−10
C6orf141 1.85 7.97E−58 3.1 IE−56
NAV3 1.85 1.21E−68 6.33E−67
HERC2P9 1.85 9.07E−20 7.09E−19
GOLGA8B 1.86 5.17E−113 7.03E−111
OPHN1 1.93 1.05E−64 4.92E−63
TAGLN 1.94 2.23E−95 2.24E−93
PRG4 1.95 6.72E−29 8.72E−28
NBPF16 1.95 1.02E−114 1.48E−112
AGAP6 1.96 2.09E−25 2.30E−24
PFN1P2 2.05 1.19E−30 1.65E−29
PPP1R11 2.18 2.28E−16 1.42E−15
HMGA2 2.19 7.78E−56 2.85E−54
SRSFIO 2.22 1.64E−22 1.53E−21
GOLGA8A 2.30 1.62E−88 1.41E−86
LOC100216001 2.32 1.88E−13 9.49E−13
NBPF14 2.34 4.08E−85 3.35E−83
LOC284454 2.42 2.30E−69 1.22E−67
ESM1 2.55 6.08E−25 6.53E−24
LOC613037 2.70 2.83E−23 2.74E−22
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Table 4 Gene ontology analysis of Esrrb-dependent DY131-altered genes
Term (down‑regulated genes) Count P value
GO:0042273 ~ ribosomal large subunit biogenesis 4 0.007
GO:0006297 ~ nucleotide-excision repair, DNA gap filling 4 0.032
GO:0006541 ~ glutamine metabolic process 4 0.042
GO:0009083 ~ branched chain family amino acid catabolic process 5 0.001
GO:0042274 ~ ribosomal small subunit biogenesis 5 0.001
GO:0009081 ~ branched chain family amino acid metabolic process 5 0.004
GO:0006904 ~ vesicle docking during exocytosis 5 0.016
GO:0048278 ~ vesicle docking 5 0.021
GO:0006958 ~ complement activation, classical pathway 5 0.031
GO:0022406 ~ membrane docking 5 0.038
GO:0002455 ~ humoral immune response mediated by circulating immunoglobulin 6 0.008
GO:0009060 ~ aerobic respiration 6 0.014
GO:0006635 ~ fatty acid beta-oxidation 7 0.001
GO:0009062 ~ fatty acid catabolic process 7 0.003
GO:0019395 ~ fatty acid oxidation 7 0.005
GO:0034440 ~ lipid oxidation 7 0.005
GO:0033559 ~ unsaturated fatty acid metabolic process 7 0.019
GO:0009064 ~ glutamine family amino acid metabolic process 7 0.020
GO:0019228 ~ regulation of action potential in neuron 7 0.024
GO:0006289 ~ nucleotide-excision repair 7 0.026
GO:0051591 ~ response to cAMP to cAMP 8 0.002
GO:0006800 ~ oxygen and reactive oxygen species metabolic process 8 0.021
GO:0001508 ~ regulation of action potential 8 0.023
GO:0009566 ~ fertilization 8 0.046
GO:0044242 ~ cellular lipid catabolic process 9 0.013
GO:0007160 ~ cell–matrix adhesion 9 0.032
GO:0060627 ~ regulation of vesicle-mediated transport 9 0.046
GO:0009063 ~ cellular amino acid catabolic process 10 0.002
GO:0045333 ~ cellular respiration 10 0.020
GO:0007568 ~ aging 10 0.040
GO:0016485 ~ protein processing 10 0.044
GO:0006364 ~ rRNA processing 11 0.005
GO:0016072 ~ rRNA metabolic process 11 0.007
GO:0006887 ~ exocytosis 11 0.022
GO:0009310 ~ amine catabolic process 12 0.000
GO:0008203 ~ cholesterol metabolic process 12 0.001
GO:0016125 ~ sterol metabolic process 12 0.003
GO:0042391 ~ regulation of membrane potential 12 0.024
GO:0015980 ~ energy derivation by oxidation of organic compounds 12 0.038
GO:0042254 ~ ribosome biogenesis 13 0.005
GO:0016053 ~ organic acid biosynthetic process 14 0.013
GO:0046394 ~ carboxylic acid biosynthetic process 14 0.013
GO:0022613 ~ ribonucleoprotein complex biogenesis 14 0.038
GO:0016042 ~ lipid catabolic process 15 0.013
GO:0006457 ~ protein folding 15 0.016
GO:0034470 ~ ncRNA processing 15 0.025
GO:0022900 ~ electron transport chain 16 0.000
GO:0032940 ~ secretion by cell 16 0.026
GO:0016054 ~ organic acid catabolic process 17 0.000
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Table 4 continued
Term (down‑regulated genes) Count P value
GO:0046395 ~ carboxylic acid catabolic process 17 0.000
GO:0034660 ~ ncRNA metabolic process 19 0.008
GO:0006631 ~ fatty acid metabolic process 21 0.000
GO:0046903 ~ secretion 22 0.014
GO:0006414 ~ translational elongation 25 0.000
GO:0008610 ~ lipid biosynthetic process 26 0.002
GO:0006091 ~ generation of precursor metabolites and energy 31 0.000
GO:0006412 ~ translation 38 0.000
GO:0016192 ~ vesicle-mediated transport 39 0.003
GO:0055114 ~ oxidation reduction 54 0.000
Term (up‑regulated genes) Count P value
GO:0002220 ~ innate immune response activating cell surface receptor signaling pathway 2 0.045
GO:0048712 ~ negative regulation of astrocyte differentiation 2 0.045
GO:0000724 ~ double-strand break repair via homologous recombination 3 0.020
GO:0000725 ~ recombinational repair 3 0.020
GO:0045987 ~ positive regulation of smooth muscle contraction 4 0.001
GO:0045933 ~ positive regulation of muscle contraction 4 0.002
GO:0006940 ~ regulation of smooth muscle contraction 4 0.009
GO:0050768 ~ negative regulation of neurogenesis 4 0.015
GO:0010721 ~ negative regulation of cell development 4 0.018
GO:0006937 ~ regulation of muscle contraction 4 0.050
GO:0048704 ~ embryonic skeletal system morphogenesis 5 0.004
GO:0048706 ~ embryonic skeletal system development 5 0.012
GO:0031344 ~ regulation of cell projection organization 5 0.019
GO:0007411 ~ axon guidance 5 0.035
GO:0051258 ~ protein polymerization 6 0.000
GO:0043623 ~ cellular protein complex assembly 6 0.039
GO:0050767 ~ regulation of neurogenesis 6 0.042
GO:0048705 ~ skeletal system morphogenesis 7 0.002
GO:0060284 ~ regulation of cell development 7 0.031
GO:0007018 ~ microtubule-based movement 8 0.000
GO:0051960 ~ regulation of nervous system development 8 0.007
GO:0006916 ~ anti-apoptosis 8 0.010
GO:0007017 ~ microtubule-based process 8 0.027
GO:0001501 ~ skeletal system development 9 0.031
GO:0006917 ~ induction of apoptosis 9 0.031
GO:0012502 ~ induction of programmed cell death 9 0.032
GO:0045596 ~ negative regulation of cell differentiation 10 0.001
GO:0040008 ~ regulation of growth 10 0.017
GO:0043066 ~ negative regulation of apoptosis 10 0.021
GO:0043069 ~ negative regulation of programmed cell death 10 0.023
GO:0060548 ~ negative regulation of cell death 10 0.023
GO:0022403 ~ cell cycle phase 10 0.049
GO:0006928 ~ cell motion 12 0.021
GO:0042127 ~ regulation of cell proliferation 17 0.018
GO:0042981 ~ regulation of apoptosis 18 0.011
GO:0043067 ~ regulation of programmed cell death 18 0.012
GO:0010941 ~ regulation of cell death 18 0.012
GO:0006355 ~ regulation of transcription, DNA-dependent 29 0.047
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manufacture’s instruction. Briefly, samples (8 total) were 
pooled into one lane with each sample annealed to a spe-
cific indexed adaptor. 50 bp single end reads were gener-
ated. For each sample, approximately 18 million reads 
were generated in.fastq format (NCBI-GEO, accession 
number: GES71208). The sequencing reads were trimmed 
and filtered using FASTX-Toolkit (V 0.0.13) (http://han-
nonlab.cshl.edu/fastx_toolkit), and mapped to genome 
(UCSC hg18) using TopHat2 [39, 40]. Gene expression 
values were determined by gene raw read counts using 
an in-house tool MULTICOM-MAP [41–43]. Raw reads 
were normalized to each sample’s library size and differ-
entially expressed genes were calculated using R/Biocon-
ductor package edgeR [44]. Specifically, we kept the genes 
that have at least 1 count-per-million (cpm) in at least 2 
samples and computed the effective library sizes. Pairwise 
gene expression tests were carried out using exact test. 
Differentially expressed genes were determined by log2 
fold change (Log2FC) (Log2FC ≥ 1, or Log2FC ≤ −1), p 
value (p < 0.05) and false discovery rate (FDR < 0.05) [45].
Gene set function enrichment
Gene ontology (GO) analysis was performed using 
DAVID bioinformatics sources 6.7 [46, 47]. Differen-
tially expressed genes from certain pairwise comparisons 
were uploaded to DAVID server (http://david.abcc.ncif-
crf.gov) and GO analysis were performed for biological 
process (BP). Minimum counts were set as default value 
(two counts) and maximum EASE score (p value) was set 
to 0.05. Differentially expressed genes pathway enrich-
ment analysis was performed using Kyoto Encyclopedia 
of Genes and Genomes (KEGG) pathway [48, 49]. Gene 
expression profiles Spearman ranking correlation analy-
sis was analyzed using R (version 3.0.2). Gene expression 
heat map and hierarchical clustering were created by R/
Bioconductor (version 2.13) package gplot.
Statistical analysis
qPCR experiments were performed in triplicate on both 
biological replicates. T test was employed to statistically 
analyze whether the differences in gene expression is 
significant (p  <  0.05). Statistical significance of gene set 
overlap (Venn Diagram) are tested according to previous 
reported method [17].
Availability of supporting data
The data sets supporting the results of this article are 
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